1 | N | N | N | N | Etretinate
 | RORB: RAR-related orphan receptor B | 0.37143 | Tretinoin
 | 0.17888 | RARB: retinoic acid receptor, beta |
2 | N | N | N | N | Norethindrone
 | ESR1: estrogen receptor 1 | 0.87500 | Levonorgestrel
 | 0.12952 | PGR: progesterone receptor |
3 | N | N | N | Y | Isotretinoin
 | RARB: retinoic acid receptor, beta | 1 | Tretinoin
 | 0.72887 | RARA: retinoic acid receptor, alpha |
4 | N | N | N | N | Tazarotene
 | RORC: RAR-related orphan receptor C | 0.14634 | Tretinoin
 | 0.45806 | RORB: RAR-related orphan receptor B |
5 | N | N | N | Y | Isotretinoin
 | RARG: retinoic acid receptor, gamma | 1 | Tretinoin
 | 0.69414 | RARA: retinoic acid receptor, alpha |
6 | N | N | N | Y | Dienestrol
 | ESR2: estrogen receptor 2 (ER beta) | 0.81818 | Diethylstilbestrol
 | 0.38529 | ESR1: estrogen receptor 1 |
7 | Y | N | N | N | Testosterone
 | PGR: progesterone receptor | 0.83333 | Progesterone
 | 0.25472 | AR: androgen receptor |
8 | Y | N | N | Y | Ethinyl estradiol
 | ESR2: estrogen receptor 2 (ER beta) | 0.82609 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
9 | N | N | N | N | Tazarotene
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.14634 | Tretinoin
 | 0.070957 | RXRA: retinoid X receptor, alpha |
10 | N | N | N | N | Fluoxymesterone
 | PGR: progesterone receptor | 0.62069 | Progesterone
 | 0.25472 | AR: androgen receptor |
11 | Y | N | N | Y | Estrone
 | ESR2: estrogen receptor 2 (ER beta) | 0.81818 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
12 | N | N | Y | Y | Mometasone furoate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.61364 | Amcinonide
 | 0.25727 | PGR: progesterone receptor |
13 | N | N | N | N | Isotretinoin
 | RXRG: retinoid X receptor, gamma | 1 | Tretinoin
 | 0.053073 | RARA: retinoic acid receptor, alpha |
14 | N | N | N | N | Hydrocortisone
 | PGR: progesterone receptor | 0.68966 | Progesterone
 | 0.25727 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
15 | Y | N | N | N | Spironolactone
 | PGR: progesterone receptor | 0.67742 | Progesterone
 | 0.23099 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
16 | N | N | N | N | Isotretinoin
 | RXRA: retinoid X receptor, alpha | 1 | Tretinoin
 | 0.23339 | RARA: retinoic acid receptor, alpha |
17 | N | N | N | N | Isotretinoin
 | RXRB: retinoid X receptor, beta | 1 | Tretinoin
 | 0.21127 | RARA: retinoic acid receptor, alpha |
18 | N | N | N | N | Tretinoin
 | RORA: RAR-related orphan receptor A | 0.19048 | Cholesterol
 | 0.57846 | RORB: RAR-related orphan receptor B |
19 | Y | N | N | N | Mifepristone
 | ESR1: estrogen receptor 1 | 0.51351 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
20 | Y | N | N | N | Testosterone
 | ESR1: estrogen receptor 1 | 0.83333 | Progesterone
 | 0.11924 | AR: androgen receptor |
21 | N | N | N | N | Ethinyl estradiol
 | PGR: progesterone receptor | 0.51724 | Norethindrone
 | 0.12952 | ESR1: estrogen receptor 1 |
22 | N | N | N | N | Cholesterol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.64706 | Cholecalciferol
 | 0.16329 | RORA: RAR-related orphan receptor A |
23 | N | N | N | N | Tretinoin
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.11111 | Palmitic acid
 | 0.30016 | RXRA: retinoid X receptor, alpha |
24 | N | N | N | N | Eplerenone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.47368 | Hydrocortisone
 | 0.27668 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
25 | N | N | N | N | Etretinate
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.37143 | Tretinoin
 | 0.070957 | RXRA: retinoid X receptor, alpha |
26 | N | N | N | N | Dydrogesterone
 | ESR1: estrogen receptor 1 | 0.84000 | Progesterone
 | 0.12952 | PGR: progesterone receptor |
27 | N | N | N | N | Nandrolone phenpropionate
 | PGR: progesterone receptor | 0.52941 | Norethindrone
 | 0.25472 | AR: androgen receptor |
28 | N | N | N | N | Hydrocortisone
 | AR: androgen receptor | 0.72414 | Fluoxymesterone
 | 0.23366 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
29 | N | N | N | N | Pregnenolone
 | PGR: progesterone receptor | 0.76923 | Progesterone
 | 0.066330 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
30 | N | N | Y | N | Fluoxymesterone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.72414 | Hydrocortisone
 | 0.23366 | AR: androgen receptor |
31 | N | N | N | N | Tretinoin
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.21951 | Chenodiol
 | 0.19755 | RARB: retinoic acid receptor, beta |
32 | N | N | N | Y | Estrone sodium sulfate
 | ESR2: estrogen receptor 2 (ER beta) | 0.60714 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
33 | Y | N | N | N | Telmisartan
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.25490 | Fenofibrate
 | 0.54439 | PPARG: peroxisome proliferator-activated receptor gamma |
34 | N | N | N | N | Etretinate
 | RORC: RAR-related orphan receptor C | 0.37143 | Tretinoin
 | 0.13240 | RARB: retinoic acid receptor, beta |
35 | N | N | N | N | Rosiglitazone maleate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.26087 | Fenofibrate
 | 0.54439 | PPARG: peroxisome proliferator-activated receptor gamma |
36 | Y | N | N | N | Fenofibrate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.26087 | Rosiglitazone maleate
 | 0.54439 | PPARA: peroxisome proliferator-activated receptor alpha |
37 | N | N | N | Y | Clomiphene citrate
 | ESR2: estrogen receptor 2 (ER beta) | 0.34783 | Diethylstilbestrol
 | 0.38529 | ESR1: estrogen receptor 1 |
38 | N | N | N | N | Chenodiol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.48718 | Calcitriol
 | 0.20226 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
39 | Y | N | N | N | Clofibrate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.22500 | Rosiglitazone maleate
 | 0.54439 | PPARA: peroxisome proliferator-activated receptor alpha |
40 | N | N | N | N | Eplerenone
 | AR: androgen receptor | 0.54286 | Fluoxymesterone
 | 0.20529 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
41 | N | N | N | N | Isotretinoin
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 1 | Tretinoin
 | 0.025033 | RARA: retinoic acid receptor, alpha |
42 | N | N | N | N | Eplerenone
 | PGR: progesterone receptor | 0.48718 | Medroxyprogesterone acetate
 | 0.23099 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
43 | N | N | N | N | Isotretinoin
 | RORB: RAR-related orphan receptor B | 1 | Tretinoin
 | 0.16340 | RARA: retinoic acid receptor, alpha |
44 | N | N | N | N | Diethylstilbestrol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.23333 | Phenobarbital
 | 0.16999 | ESRRA: estrogen-related receptor alpha |
45 | N | N | N | N | Mometasone furoate
 | ESR1: estrogen receptor 1 | 0.47500 | Fluoxymesterone
 | 0.12952 | PGR: progesterone receptor |
46 | Y | N | N | N | Spironolactone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.52778 | Hydrocortisone
 | 0.27668 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
47 | N | N | N | N | Diethylstilbestrol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.085714 | Palmitic acid
 | 0.19965 | ESRRG: estrogen-related receptor gamma |
48 | N | N | N | N | Norethindrone
 | AR: androgen receptor | 0.72000 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
49 | N | N | N | N | Tazarotene
 | ESR1: estrogen receptor 1 | 0.40625 | Diethylstilbestrol
 | 0.18294 | RXRA: retinoid X receptor, alpha |
50 | Y | N | Y | N | Medroxyprogesterone acetate
 | ESR1: estrogen receptor 1 | 0.70000 | Progesterone
 | 0.12952 | PGR: progesterone receptor |
51 | N | N | N | N | Pregnenolone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.45714 | Cholecalciferol
 | 0.35863 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
52 | N | N | N | N | Dienestrol
 | ESRRG: estrogen-related receptor gamma | 0.81818 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
53 | N | N | N | N | Hydrocortisone
 | ESR1: estrogen receptor 1 | 0.72414 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
54 | N | N | N | N | Dienestrol
 | ESRRB: estrogen-related receptor beta | 0.81818 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
55 | N | N | N | N | Isotretinoin
 | RORC: RAR-related orphan receptor C | 1 | Tretinoin
 | 0.12557 | RARA: retinoic acid receptor, alpha |
56 | N | N | N | N | Dienestrol
 | ESRRA: estrogen-related receptor alpha | 0.81818 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
57 | N | N | N | N | Tretinoin
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.054054 | Phenobarbital
 | 0.18237 | RARG: retinoic acid receptor, gamma |
58 | N | N | N | N | Hydrocortisone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.52778 | Spironolactone
 | 0.27668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
59 | N | N | N | N | Nandrolone phenpropionate
 | ESR1: estrogen receptor 1 | 0.51429 | Progesterone
 | 0.11924 | AR: androgen receptor |
60 | N | N | N | N | Testosterone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.67857 | Hydrocortisone
 | 0.23366 | AR: androgen receptor |
61 | N | Y | N | N | Phenobarbital
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.29167 | Butamben
 | 0.32482 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
62 | N | N | N | N | Diethylstilbestrol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.45161 | Fenofibrate
 | 0.14241 | ESRRG: estrogen-related receptor gamma |
63 | N | N | N | N | Imatinib mesylate
 | RORB: RAR-related orphan receptor B | 0.31372 | Tazarotene
 | 0.57846 | RORA: RAR-related orphan receptor A |
64 | N | N | N | N | Estrone
 | PGR: progesterone receptor | 0.44828 | Norethindrone
 | 0.12952 | ESR1: estrogen receptor 1 |
65 | Y | N | Y | N | Spironolactone
 | AR: androgen receptor | 0.56250 | Testosterone
 | 0.20529 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
66 | N | N | N | N | Tretinoin
 | ESRRG: estrogen-related receptor gamma | 0.076923 | Diethylstilbestrol
 | 0.25042 | RXRA: retinoid X receptor, alpha |
67 | N | N | N | N | Tazarotene
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.42857 | Fenofibrate
 | 0.21233 | RARB: retinoic acid receptor, beta |
68 | N | N | N | N | Tretinoin
 | ESRRA: estrogen-related receptor alpha | 0.076923 | Diethylstilbestrol
 | 0.23672 | RXRA: retinoid X receptor, alpha |
69 | N | N | N | N | Loteprednol etabonate
 | PGR: progesterone receptor | 0.59524 | Mometasone furoate
 | 0.25727 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
70 | N | N | N | N | Diethylstilbestrol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.090909 | Chenodiol
 | 0.15388 | ESRRG: estrogen-related receptor gamma |
71 | N | N | N | N | Butamben
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.50000 | Clofibrate
 | 0.14611 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
72 | N | N | N | N | Tretinoin
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10909 | Telmisartan
 | 0.20203 | RARB: retinoic acid receptor, beta |
73 | N | N | N | N | Diethylstilbestrol
 | RXRA: retinoid X receptor, alpha | 0.40625 | Tazarotene
 | 0.25042 | ESRRG: estrogen-related receptor gamma |
74 | N | N | N | N | Estrone sodium sulfate
 | PGR: progesterone receptor | 0.35714 | Mifepristone
 | 0.12952 | ESR1: estrogen receptor 1 |
75 | N | N | N | N | Tretinoin
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Ergocalciferol
 | 0.18311 | RARG: retinoic acid receptor, gamma |
76 | N | N | N | N | Amcinonide
 | PGR: progesterone receptor | 0.61364 | Mometasone furoate
 | 0.25727 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
77 | N | N | N | N | Chenodiol
 | RORA: RAR-related orphan receptor A | 0.60000 | Cholesterol
 | 0.13581 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
78 | N | N | N | N | Tretinoin
 | ESRRB: estrogen-related receptor beta | 0.076923 | Diethylstilbestrol
 | 0.23259 | RXRA: retinoid X receptor, alpha |
79 | N | N | N | N | Oxandrolone
 | ESR1: estrogen receptor 1 | 0.50000 | Progesterone
 | 0.11924 | AR: androgen receptor |
80 | N | N | N | N | Tazarotene
 | RORA: RAR-related orphan receptor A | 0.31372 | Imatinib mesylate
 | 0.57846 | RORB: RAR-related orphan receptor B |
81 | N | N | N | N | Diethylstilbestrol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.29268 | Rosiglitazone maleate
 | 0.14244 | ESRRG: estrogen-related receptor gamma |
82 | Y | N | N | N | Medroxyprogesterone acetate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.58823 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
83 | N | N | N | N | Tretinoin
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.093023 | Fenofibrate
 | 0.21233 | RARB: retinoic acid receptor, beta |
84 | N | N | N | N | Butamben
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.29167 | Phenobarbital
 | 0.32482 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
85 | N | N | N | N | Pregnenolone
 | ESR1: estrogen receptor 1 | 0.76923 | Progesterone
 | 0.095273 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
86 | N | N | N | N | Fluoxymesterone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.54286 | Eplerenone
 | 0.20529 | AR: androgen receptor |
87 | N | N | N | N | Diethylstilbestrol
 | RXRB: retinoid X receptor, beta | 0.40625 | Tazarotene
 | 0.21699 | ESRRA: estrogen-related receptor alpha |
88 | N | N | N | N | Rifampin
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.21094 | Calcitriol
 | 0.35863 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
89 | N | N | N | N | Isotretinoin
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Ergocalciferol
 | 0.17498 | RARA: retinoic acid receptor, alpha |
90 | N | N | N | N | Tazarotene
 | ESR2: estrogen receptor 2 (ER beta) | 0.40625 | Diethylstilbestrol
 | 0.16853 | RXRA: retinoid X receptor, alpha |
91 | N | N | N | N | Cholesterol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.60000 | Chenodiol
 | 0.13581 | RORA: RAR-related orphan receptor A |
92 | N | N | N | N | Pregnenolone
 | RORA: RAR-related orphan receptor A | 0.70000 | Cholesterol
 | 0.13841 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
93 | N | N | N | N | Cholesterol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.70000 | Pregnenolone
 | 0.13841 | RORA: RAR-related orphan receptor A |
94 | N | N | N | N | Nandrolone phenpropionate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.47619 | Mifepristone
 | 0.23366 | AR: androgen receptor |
95 | N | N | N | N | Chenodiol
 | ESR1: estrogen receptor 1 | 0.45714 | Progesterone
 | 0.11758 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
96 | N | N | N | N | Chenodiol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.54546 | Pregnenolone
 | 0.18905 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
97 | N | N | N | N | Cholesterol
 | RORB: RAR-related orphan receptor B | 0.19048 | Tretinoin
 | 0.57846 | RORA: RAR-related orphan receptor A |
98 | N | N | N | N | Loteprednol etabonate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.44186 | Eplerenone
 | 0.27668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
99 | N | N | N | N | Cholesterol
 | PGR: progesterone receptor | 0.54546 | Progesterone
 | 0.057820 | RORA: RAR-related orphan receptor A |
100 | N | N | N | N | Amcinonide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.43478 | Eplerenone
 | 0.27668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
101 | N | N | N | N | Mometasone furoate
 | AR: androgen receptor | 0.47500 | Fluoxymesterone
 | 0.25472 | PGR: progesterone receptor |
102 | N | N | N | N | Imatinib mesylate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.37288 | Telmisartan
 | 0.17144 | RORA: RAR-related orphan receptor A |
103 | N | N | N | N | Palmitic acid
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.15909 | Rosiglitazone maleate
 | 0.13124 | HNF4G: hepatocyte nuclear factor 4, gamma |
104 | N | N | N | N | Estrone
 | AR: androgen receptor | 0.47059 | Nandrolone phenpropionate
 | 0.11924 | ESR1: estrogen receptor 1 |
105 | N | N | N | N | Diethylstilbestrol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.20930 | Mifepristone
 | 0.13692 | ESRRA: estrogen-related receptor alpha |
106 | N | N | N | N | Phenobarbital
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.28205 | Rosiglitazone maleate
 | 0.12510 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
107 | N | N | N | N | Oxandrolone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.50000 | Spironolactone
 | 0.20529 | AR: androgen receptor |
108 | N | N | N | N | Ethinyl estradiol
 | AR: androgen receptor | 0.45946 | Mifepristone
 | 0.11924 | ESR1: estrogen receptor 1 |
109 | N | N | N | N | Diethylstilbestrol
 | AR: androgen receptor | 0.36111 | Bicalutamide
 | 0.12419 | ESRRA: estrogen-related receptor alpha |
110 | N | N | N | N | Diethylstilbestrol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.20930 | Mifepristone
 | 0.16148 | ESRRG: estrogen-related receptor gamma |
111 | N | N | N | N | Telmisartan
 | RORA: RAR-related orphan receptor A | 0.37288 | Imatinib mesylate
 | 0.17144 | PPARG: peroxisome proliferator-activated receptor gamma |
112 | N | N | N | N | Clofibrate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.50000 | Butamben
 | 0.14611 | PPARA: peroxisome proliferator-activated receptor alpha |
113 | Y | N | N | N | Bicalutamide
 | ESR1: estrogen receptor 1 | 0.36111 | Diethylstilbestrol
 | 0.11924 | AR: androgen receptor |
114 | Y | N | N | N | Progesterone
 | AR: androgen receptor | 0.83333 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
115 | N | N | N | N | Loteprednol etabonate
 | AR: androgen receptor | 0.51351 | Fluoxymesterone
 | 0.23366 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
116 | N | N | N | N | Estrone sodium sulfate
 | AR: androgen receptor | 0.41026 | Nandrolone phenpropionate
 | 0.11924 | ESR1: estrogen receptor 1 |
117 | N | N | N | N | Budesonide
 | PGR: progesterone receptor | 0.57143 | Mometasone furoate
 | 0.25727 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
118 | N | N | N | N | Imatinib mesylate
 | ESR1: estrogen receptor 1 | 0.45283 | Raloxifene hydrochloride
 | 0.085339 | RORA: RAR-related orphan receptor A |
119 | N | N | N | N | Phenobarbital
 | AR: androgen receptor | 0.34483 | Nilutamide
 | 0.087787 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
120 | N | N | N | N | Phenobarbital
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.26923 | Clofibrate
 | 0.12527 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
121 | N | N | N | N | Pregnenolone
 | AR: androgen receptor | 0.62963 | Testosterone
 | 0.064846 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
122 | N | N | N | N | Testosterone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.56250 | Spironolactone
 | 0.20529 | AR: androgen receptor |
123 | N | N | N | N | Clomiphene citrate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.38889 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
124 | Y | N | N | N | Mifepristone
 | ESR2: estrogen receptor 2 (ER beta) | 0.40541 | Estradiol
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
125 | N | N | N | N | Diethylstilbestrol
 | RARG: retinoic acid receptor, gamma | 0.40625 | Tazarotene
 | 0.23110 | ESRRG: estrogen-related receptor gamma |
126 | N | N | N | N | Nandrolone phenpropionate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.47619 | Mifepristone
 | 0.20529 | AR: androgen receptor |
127 | Y | N | N | N | Medroxyprogesterone acetate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.54054 | Spironolactone
 | 0.23099 | PGR: progesterone receptor |
128 | N | N | N | N | Tretinoin
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17391 | Mifepristone
 | 0.095503 | RARG: retinoic acid receptor, gamma |
129 | N | N | N | N | Palmitic acid
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.15000 | Chenodiol
 | 0.13052 | HNF4G: hepatocyte nuclear factor 4, gamma |
130 | N | N | N | N | Etretinate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.35484 | Clofibrate
 | 0.21233 | RARB: retinoic acid receptor, beta |
131 | N | N | N | N | Fenofibrate
 | ESR1: estrogen receptor 1 | 0.45161 | Diethylstilbestrol
 | 0.092842 | PPARA: peroxisome proliferator-activated receptor alpha |
132 | N | N | N | N | Fluoxymesterone
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
133 | N | N | N | N | Pregnenolone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.54546 | Chenodiol
 | 0.18905 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
134 | N | N | N | N | Amcinonide
 | AR: androgen receptor | 0.46342 | Fluoxymesterone
 | 0.23366 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
135 | N | N | N | N | Tazarotene
 | ESRRG: estrogen-related receptor gamma | 0.40625 | Diethylstilbestrol
 | 0.25042 | RXRA: retinoid X receptor, alpha |
136 | N | N | N | N | Cholesterol
 | RORC: RAR-related orphan receptor C | 0.19048 | Tretinoin
 | 0.43008 | RORA: RAR-related orphan receptor A |
137 | N | N | N | N | Rosiglitazone maleate
 | ESR1: estrogen receptor 1 | 0.38889 | Clomiphene citrate
 | 0.10925 | PPARG: peroxisome proliferator-activated receptor gamma |
138 | N | N | N | N | Budesonide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.39535 | Spironolactone
 | 0.27668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
139 | N | N | Y | N | Norgestrel
 | AR: androgen receptor | 0.69231 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
140 | N | N | Y | N | Levonorgestrel
 | AR: androgen receptor | 0.69231 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
141 | N | N | N | N | Tazarotene
 | ESRRA: estrogen-related receptor alpha | 0.40625 | Diethylstilbestrol
 | 0.23672 | RXRA: retinoid X receptor, alpha |
142 | N | N | N | N | Desogestrel
 | ESR2: estrogen receptor 2 (ER beta) | 0.34375 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
143 | N | N | N | N | Cholecalciferol
 | RORA: RAR-related orphan receptor A | 0.64706 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
144 | N | N | N | N | Chenodiol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.15000 | Palmitic acid
 | 0.13052 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
145 | N | N | N | N | Palmitic acid
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.060606 | Phenobarbital
 | 0.15269 | HNF4G: hepatocyte nuclear factor 4, gamma |
146 | N | N | N | N | Norethindrone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.50000 | Spironolactone
 | 0.23099 | PGR: progesterone receptor |
147 | N | N | N | N | Estramustine
 | PGR: progesterone receptor | 0.36170 | Mometasone furoate
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
148 | N | N | N | N | Diethylstilbestrol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.36000 | Butamben
 | 0.12402 | ESRRA: estrogen-related receptor alpha |
149 | Y | N | N | N | Progesterone
 | ESR2: estrogen receptor 2 (ER beta) | 0.38710 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
150 | Y | N | N | N | Mifepristone
 | ESRRA: estrogen-related receptor alpha | 0.20930 | Diethylstilbestrol
 | 0.15441 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
151 | N | N | N | N | Diethylstilbestrol
 | RARA: retinoic acid receptor, alpha | 0.40625 | Tazarotene
 | 0.21526 | ESRRG: estrogen-related receptor gamma |
152 | N | N | N | N | Dydrogesterone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.62500 | Spironolactone
 | 0.23099 | PGR: progesterone receptor |
153 | N | N | N | N | Imatinib mesylate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.28846 | Fenofibrate
 | 0.16545 | RORA: RAR-related orphan receptor A |
154 | N | N | N | N | Phenobarbital
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.060606 | Palmitic acid
 | 0.15269 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
155 | N | N | N | N | Norethindrone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.60000 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
156 | N | N | N | N | Imatinib mesylate
 | RORC: RAR-related orphan receptor C | 0.084746 | Tretinoin
 | 0.43008 | RORA: RAR-related orphan receptor A |
157 | N | N | N | N | Tretinoin
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.18421 | Pregnenolone
 | 0.17437 | RARB: retinoic acid receptor, beta |
158 | N | N | N | N | Raloxifene hydrochloride
 | ESRRA: estrogen-related receptor alpha | 0.34146 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
159 | Y | N | N | N | Spironolactone
 | ESR1: estrogen receptor 1 | 0.67742 | Progesterone
 | 0.12027 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
160 | N | N | N | N | Dydrogesterone
 | AR: androgen receptor | 0.69231 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
161 | N | N | N | N | Diethylstilbestrol
 | RORA: RAR-related orphan receptor A | 0.25265 | Imatinib mesylate
 | 0.094996 | ESRRA: estrogen-related receptor alpha |
162 | N | N | N | N | Rifampin
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.10145 | Phenobarbital
 | 0.32482 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
163 | N | N | N | N | Diethylstilbestrol
 | RARB: retinoic acid receptor, beta | 0.40625 | Tazarotene
 | 0.20606 | ESRRG: estrogen-related receptor gamma |
164 | N | N | N | N | Tazarotene
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.26087 | Rosiglitazone maleate
 | 0.20203 | RARB: retinoic acid receptor, beta |
165 | Y | N | N | N | Estradiol
 | ESRRA: estrogen-related receptor alpha | 0.25000 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
166 | Y | N | N | N | Estradiol
 | AR: androgen receptor | 0.47059 | Nandrolone phenpropionate
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
167 | N | N | N | N | Cholesterol
 | AR: androgen receptor | 0.53125 | Testosterone
 | 0.055679 | RORA: RAR-related orphan receptor A |
168 | N | N | N | N | Tazarotene
 | ESRRB: estrogen-related receptor beta | 0.40625 | Diethylstilbestrol
 | 0.23259 | RXRA: retinoid X receptor, alpha |
169 | N | N | N | N | Chenodiol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.11667 | Telmisartan
 | 0.17153 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
170 | N | N | N | N | Cholecalciferol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.45714 | Pregnenolone
 | 0.35863 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
171 | N | N | N | N | Diethylstilbestrol
 | RORC: RAR-related orphan receptor C | 0.076923 | Tretinoin
 | 0.093967 | ESRRG: estrogen-related receptor gamma |
172 | N | N | N | N | Chenodiol
 | AR: androgen receptor | 0.51515 | Oxandrolone
 | 0.081683 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
173 | N | N | N | N | Diethylstilbestrol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.076923 | Tretinoin
 | 0.051885 | ESRRG: estrogen-related receptor gamma |
174 | N | N | N | N | Mifepristone
 | ESRRG: estrogen-related receptor gamma | 0.20930 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
175 | N | N | N | N | Raloxifene hydrochloride
 | ESRRG: estrogen-related receptor gamma | 0.34146 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
176 | Y | N | N | N | Estradiol
 | ESRRG: estrogen-related receptor gamma | 0.25000 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
177 | N | N | N | N | Oxandrolone
 | PGR: progesterone receptor | 0.50000 | Progesterone
 | 0.25472 | AR: androgen receptor |
178 | Y | N | N | N | Medroxyprogesterone acetate
 | AR: androgen receptor | 0.58064 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
179 | N | N | N | N | Pregnenolone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.58064 | Hydrocortisone
 | 0.071609 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
180 | N | N | N | N | Phenobarbital
 | ESR1: estrogen receptor 1 | 0.23333 | Estrone
 | 0.12743 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
181 | N | N | N | N | Calcitriol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.39474 | Pregnenolone
 | 0.35863 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
182 | N | N | N | N | Budesonide
 | AR: androgen receptor | 0.48649 | Fluoxymesterone
 | 0.23366 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
183 | N | N | N | N | Tazarotene
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.048780 | Palmitic acid
 | 0.30016 | RXRA: retinoid X receptor, alpha |
184 | N | N | N | N | Butamben
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.23684 | Rosiglitazone maleate
 | 0.16215 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
185 | N | N | N | N | Oxandrolone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.45454 | Hydrocortisone
 | 0.23366 | AR: androgen receptor |
186 | Y | N | Y | N | Progesterone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.67742 | Spironolactone
 | 0.23099 | PGR: progesterone receptor |
187 | N | N | N | N | Phenobarbital
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.046512 | Chenodiol
 | 0.19003 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
188 | N | N | N | N | Fenofibrate
 | AR: androgen receptor | 0.38461 | Bicalutamide
 | 0.061430 | PPARA: peroxisome proliferator-activated receptor alpha |
189 | N | N | N | N | Bicalutamide
 | ESR2: estrogen receptor 2 (ER beta) | 0.36111 | Diethylstilbestrol
 | 0.11996 | AR: androgen receptor |
190 | N | N | N | N | Palmitic acid
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.14286 | Butamben
 | 0.11513 | HNF4G: hepatocyte nuclear factor 4, gamma |
191 | N | N | N | N | Oxandrolone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.36842 | Paricalcitol
 | 0.067869 | AR: androgen receptor |
192 | N | N | N | N | Dihydrotachysterol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.40541 | Pregnenolone
 | 0.35863 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
193 | N | N | N | N | Rosiglitazone maleate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.28205 | Phenobarbital
 | 0.12510 | PPARG: peroxisome proliferator-activated receptor gamma |
194 | N | N | N | N | Dienestrol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.45161 | Fenofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
195 | N | N | N | N | Pregnenolone
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.57576 | Spironolactone
 | 0.075614 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
196 | N | N | N | N | Estramustine
 | AR: androgen receptor | 0.43902 | Nandrolone phenpropionate
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
197 | N | N | N | N | Butamben
 | ESR1: estrogen receptor 1 | 0.36000 | Diethylstilbestrol
 | 0.095273 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
198 | N | N | N | N | Fenofibrate
 | RORA: RAR-related orphan receptor A | 0.28846 | Imatinib mesylate
 | 0.16545 | PPARA: peroxisome proliferator-activated receptor alpha |
199 | N | N | N | N | Ergocalciferol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.44444 | Pregnenolone
 | 0.35863 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
200 | N | N | N | N | Cholesterol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.45946 | Hydrocortisone
 | 0.061022 | RORA: RAR-related orphan receptor A |
201 | N | N | N | N | Raloxifene hydrochloride
 | ESRRB: estrogen-related receptor beta | 0.34146 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
202 | N | N | N | N | Chenodiol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.42500 | Spironolactone
 | 0.085591 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
203 | Y | N | N | N | Estradiol
 | ESRRB: estrogen-related receptor beta | 0.25000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
204 | N | N | N | N | Fulvestrant
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.28261 | Palmitic acid
 | 0.14814 | ESR2: estrogen receptor 2 (ER beta) |
205 | N | N | N | N | Phenobarbital
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.046512 | Cholecalciferol
 | 0.27216 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
206 | N | N | N | N | Cholesterol
 | ESR1: estrogen receptor 1 | 0.54546 | Progesterone
 | 0.085339 | RORA: RAR-related orphan receptor A |
207 | N | N | N | N | Loteprednol etabonate
 | ESR1: estrogen receptor 1 | 0.51351 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
208 | N | N | N | N | Mometasone furoate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.41304 | Eplerenone
 | 0.23099 | PGR: progesterone receptor |
209 | N | N | N | N | Palmitic acid
 | RORA: RAR-related orphan receptor A | 0.095238 | Cholesterol
 | 0.097709 | HNF4G: hepatocyte nuclear factor 4, gamma |
210 | N | N | N | N | Bicalutamide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.38461 | Fenofibrate
 | 0.061430 | AR: androgen receptor |
211 | N | N | N | N | Clofibrate
 | AR: androgen receptor | 0.25000 | Flutamide
 | 0.061430 | PPARA: peroxisome proliferator-activated receptor alpha |
212 | N | N | N | N | Mifepristone
 | ESRRB: estrogen-related receptor beta | 0.20930 | Diethylstilbestrol
 | 0.14423 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
213 | N | N | N | N | Tazarotene
 | AR: androgen receptor | 0.31707 | Bicalutamide
 | 0.10468 | RXRA: retinoid X receptor, alpha |
214 | N | N | N | N | Spironolactone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.57576 | Pregnenolone
 | 0.075614 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
215 | N | N | N | N | Palmitic acid
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.062500 | Clofibrate
 | 0.13213 | HNF4G: hepatocyte nuclear factor 4, gamma |
216 | N | N | N | N | Clofibrate
 | RARA: retinoic acid receptor, alpha | 0.41379 | Tazarotene
 | 0.20153 | PPARA: peroxisome proliferator-activated receptor alpha |
217 | N | N | N | N | Dydrogesterone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.70370 | Pregnenolone
 | 0.066330 | PGR: progesterone receptor |
218 | N | N | N | N | Paricalcitol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.39474 | Pregnenolone
 | 0.35863 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
219 | N | N | N | N | Nilutamide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.34483 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
220 | N | N | N | N | Diethylstilbestrol
 | RORB: RAR-related orphan receptor B | 0.40625 | Tazarotene
 | 0.10275 | ESRRA: estrogen-related receptor alpha |
221 | N | N | N | N | Tazarotene
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.34483 | Butamben
 | 0.17437 | RARB: retinoic acid receptor, beta |
222 | N | N | N | N | Chenodiol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.046512 | Phenobarbital
 | 0.19003 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
223 | N | N | N | N | Oxandrolone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.51515 | Chenodiol
 | 0.081683 | AR: androgen receptor |
224 | N | N | N | N | Telmisartan
 | ESR1: estrogen receptor 1 | 0.29608 | Clomiphene citrate
 | 0.10925 | PPARG: peroxisome proliferator-activated receptor gamma |
225 | Y | N | N | N | Progesterone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.68966 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
226 | Y | N | N | N | Estradiol
 | PGR: progesterone receptor | 0.40541 | Mifepristone
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
227 | N | N | N | N | Chenodiol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.42105 | Hydrocortisone
 | 0.092251 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
228 | N | N | N | N | Ethynodiol diacetate
 | ESR2: estrogen receptor 2 (ER beta) | 0.32558 | Estramustine
 | 0.38529 | ESR1: estrogen receptor 1 |
229 | N | N | N | N | Dihydrotachysterol
 | RARA: retinoic acid receptor, alpha | 0.34210 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
230 | N | N | N | N | Etretinate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.047619 | Palmitic acid
 | 0.30016 | RXRA: retinoid X receptor, alpha |
231 | N | N | N | N | Tazarotene
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.10417 | Chenodiol
 | 0.19755 | RARB: retinoic acid receptor, beta |
232 | N | N | N | N | Norgestrel
 | ESR2: estrogen receptor 2 (ER beta) | 0.34375 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
233 | N | N | N | N | Levonorgestrel
 | ESR2: estrogen receptor 2 (ER beta) | 0.34375 | Estradiol
 | 0.38529 | ESR1: estrogen receptor 1 |
234 | N | N | N | N | Clofibrate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.26923 | Phenobarbital
 | 0.12527 | PPARA: peroxisome proliferator-activated receptor alpha |
235 | N | N | N | N | Telmisartan
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.20455 | Butamben
 | 0.16215 | PPARG: peroxisome proliferator-activated receptor gamma |
236 | N | N | N | N | Imatinib mesylate
 | AR: androgen receptor | 0.32722 | Bicalutamide
 | 0.055679 | RORA: RAR-related orphan receptor A |
237 | N | N | N | N | Norgestrel
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.58064 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
238 | N | N | N | N | Levonorgestrel
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.58064 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
239 | N | N | N | N | Spironolactone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.42500 | Chenodiol
 | 0.085591 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
240 | N | N | N | N | Imatinib mesylate
 | ESR2: estrogen receptor 2 (ER beta) | 0.45283 | Raloxifene hydrochloride
 | 0.088647 | RORA: RAR-related orphan receptor A |
241 | N | N | N | N | Chenodiol
 | PGR: progesterone receptor | 0.45714 | Progesterone
 | 0.077571 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
242 | Y | N | N | N | Eplerenone
 | ESR1: estrogen receptor 1 | 0.54286 | Fluoxymesterone
 | 0.12027 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
243 | N | N | N | N | Calcitriol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.48718 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
244 | N | N | N | N | Dihydrotachysterol
 | PGR: progesterone receptor | 0.35714 | Medroxyprogesterone acetate
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
245 | N | N | N | N | Rosiglitazone maleate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.15909 | Palmitic acid
 | 0.13124 | PPARG: peroxisome proliferator-activated receptor gamma |
246 | N | N | N | N | Calcitriol
 | ESR1: estrogen receptor 1 | 0.35897 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
247 | N | N | N | N | Ergocalciferol
 | RARA: retinoic acid receptor, alpha | 0.34210 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
248 | N | N | N | N | Diethylstilbestrol
 | PGR: progesterone receptor | 0.20930 | Mifepristone
 | 0.14238 | ESRRA: estrogen-related receptor alpha |
249 | N | N | N | N | Fulvestrant
 | ESRRA: estrogen-related receptor alpha | 0.17308 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
250 | N | N | N | N | Clofibrate
 | ESR1: estrogen receptor 1 | 0.33333 | Diethylstilbestrol
 | 0.092842 | PPARA: peroxisome proliferator-activated receptor alpha |
251 | N | N | N | N | Telmisartan
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.14000 | Palmitic acid
 | 0.13124 | PPARG: peroxisome proliferator-activated receptor gamma |
252 | N | N | N | N | Eplerenone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.28889 | Cholecalciferol
 | 0.076190 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
253 | N | N | N | N | Rifampin
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.26667 | Amcinonide
 | 0.071609 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
254 | N | N | N | N | Raloxifene hydrochloride
 | RORA: RAR-related orphan receptor A | 0.45283 | Imatinib mesylate
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
255 | N | N | N | N | Estramustine
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.38636 | Loteprednol etabonate
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
256 | N | N | N | N | Mifepristone
 | RXRA: retinoid X receptor, alpha | 0.23913 | Tazarotene
 | 0.11451 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
257 | N | N | N | N | Norgestrel
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.48649 | Mifepristone
 | 0.23099 | PGR: progesterone receptor |
258 | N | N | N | N | Levonorgestrel
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.48649 | Mifepristone
 | 0.23099 | PGR: progesterone receptor |
259 | N | N | N | N | Rosiglitazone maleate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.23684 | Butamben
 | 0.16215 | PPARG: peroxisome proliferator-activated receptor gamma |
260 | N | N | N | N | Desogestrel
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
261 | N | N | N | N | Palmitic acid
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.11111 | Tretinoin
 | 0.067201 | HNF4G: hepatocyte nuclear factor 4, gamma |
262 | N | N | N | N | Etretinate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.22222 | Dihydrotachysterol
 | 0.18311 | RARG: retinoic acid receptor, gamma |
263 | N | N | N | N | Tazarotene
 | PGR: progesterone receptor | 0.23913 | Mifepristone
 | 0.10416 | RXRA: retinoid X receptor, alpha |
264 | N | N | N | N | Tretinoin
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17391 | Mifepristone
 | 0.11451 | RXRA: retinoid X receptor, alpha |
265 | N | N | N | N | Phenobarbital
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.19512 | Mifepristone
 | 0.094019 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
266 | N | N | N | N | Flutamide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.29412 | Fenofibrate
 | 0.061430 | AR: androgen receptor |
267 | N | N | N | N | Fenofibrate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.30000 | Butamben
 | 0.14611 | PPARA: peroxisome proliferator-activated receptor alpha |
268 | N | N | N | N | Rosiglitazone maleate
 | AR: androgen receptor | 0.24000 | Bicalutamide
 | 0.063846 | PPARG: peroxisome proliferator-activated receptor gamma |
269 | N | N | N | N | Tazarotene
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.16667 | Phenobarbital
 | 0.18237 | RARG: retinoic acid receptor, gamma |
270 | N | N | N | N | Chenodiol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.081633 | Fenofibrate
 | 0.15232 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
271 | N | N | N | N | Estramustine
 | ESRRA: estrogen-related receptor alpha | 0.19512 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
272 | N | N | N | N | Phenobarbital
 | RORA: RAR-related orphan receptor A | 0.11321 | Imatinib mesylate
 | 0.10498 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
273 | N | N | N | N | Pregnenolone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.052632 | Phenobarbital
 | 0.32482 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
274 | N | N | N | N | Mifepristone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.19512 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
275 | N | N | N | N | Butamben
 | ESR2: estrogen receptor 2 (ER beta) | 0.36000 | Diethylstilbestrol
 | 0.088787 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
276 | N | N | N | N | Telmisartan
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.11667 | Chenodiol
 | 0.17153 | PPARG: peroxisome proliferator-activated receptor gamma |
277 | N | N | N | N | Phenobarbital
 | ESRRA: estrogen-related receptor alpha | 0.23333 | Diethylstilbestrol
 | 0.16999 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
278 | N | N | N | N | Dydrogesterone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.58064 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
279 | N | N | N | N | Paricalcitol
 | RARA: retinoic acid receptor, alpha | 0.33333 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
280 | N | N | N | N | Mifepristone
 | RXRB: retinoid X receptor, beta | 0.23913 | Tazarotene
 | 0.10128 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
281 | N | N | N | N | Fulvestrant
 | ESRRG: estrogen-related receptor gamma | 0.17308 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
282 | N | N | N | N | Desogestrel
 | AR: androgen receptor | 0.51724 | Testosterone
 | 0.25472 | PGR: progesterone receptor |
283 | N | N | N | N | Chenodiol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.21951 | Tretinoin
 | 0.036079 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
284 | N | N | N | N | Amcinonide
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.30612 | Cholecalciferol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
285 | N | N | N | N | Bicalutamide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.24000 | Rosiglitazone maleate
 | 0.063846 | AR: androgen receptor |
286 | N | N | N | N | Spironolactone
 | RORA: RAR-related orphan receptor A | 0.42500 | Cholesterol
 | 0.061072 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
287 | N | N | N | N | Rosiglitazone maleate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.10909 | Cholecalciferol
 | 0.18238 | PPARG: peroxisome proliferator-activated receptor gamma |
288 | N | N | N | N | Palmitic acid
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.095238 | Cholecalciferol
 | 0.11942 | HNF4G: hepatocyte nuclear factor 4, gamma |
289 | N | N | N | N | Ergocalciferol
 | RORA: RAR-related orphan receptor A | 0.54054 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
290 | N | N | N | N | Cholecalciferol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.47368 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
291 | N | N | N | N | Calcitriol
 | RORA: RAR-related orphan receptor A | 0.52632 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
292 | N | N | N | N | Budesonide
 | ESR1: estrogen receptor 1 | 0.48649 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
293 | N | N | N | N | Phenobarbital
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.19512 | Mifepristone
 | 0.10736 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
294 | N | N | N | N | Estramustine
 | ESRRG: estrogen-related receptor gamma | 0.19512 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
295 | N | N | N | N | Eplerenone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.39474 | Pregnenolone
 | 0.075614 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
296 | N | N | N | N | Palmitic acid
 | ESR1: estrogen receptor 1 | 0.28261 | Fulvestrant
 | 0.14077 | HNF4G: hepatocyte nuclear factor 4, gamma |
297 | N | N | N | N | Tazarotene
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.23913 | Mifepristone
 | 0.095503 | RARG: retinoic acid receptor, gamma |
298 | N | N | N | N | Cholesterol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.42500 | Spironolactone
 | 0.061072 | RORA: RAR-related orphan receptor A |
299 | N | N | N | N | Hydrocortisone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.58064 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
300 | N | N | N | N | Phenobarbital
 | ESRRB: estrogen-related receptor beta | 0.23333 | Diethylstilbestrol
 | 0.15794 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
301 | N | N | N | N | Paricalcitol
 | ESR1: estrogen receptor 1 | 0.35897 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
302 | N | N | N | N | Diethylstilbestrol
 | RXRG: retinoid X receptor, gamma | 0.40625 | Tazarotene
 | 0.040802 | ESRRG: estrogen-related receptor gamma |
303 | N | N | N | N | Ethynodiol diacetate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.46342 | Loteprednol etabonate
 | 0.25727 | PGR: progesterone receptor |
304 | N | N | N | N | Butamben
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.14286 | Palmitic acid
 | 0.11513 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
305 | N | N | N | N | Amcinonide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.37209 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
306 | N | N | N | N | Mifepristone
 | RXRG: retinoid X receptor, gamma | 0.23913 | Tazarotene
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
307 | N | N | N | N | Paricalcitol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.45000 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
308 | N | N | N | N | Mifepristone
 | RARG: retinoic acid receptor, gamma | 0.23913 | Tazarotene
 | 0.099896 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
309 | N | N | N | N | Rosiglitazone maleate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.10909 | Chenodiol
 | 0.17153 | PPARG: peroxisome proliferator-activated receptor gamma |
310 | N | N | N | N | Clofibrate
 | RARB: retinoic acid receptor, beta | 0.41379 | Tazarotene
 | 0.21233 | PPARA: peroxisome proliferator-activated receptor alpha |
311 | N | N | N | N | Nilutamide
 | ESR1: estrogen receptor 1 | 0.31250 | Estrone
 | 0.11924 | AR: androgen receptor |
312 | N | N | N | N | Etretinate
 | ESR1: estrogen receptor 1 | 0.17949 | Diethylstilbestrol
 | 0.18294 | RXRA: retinoid X receptor, alpha |
313 | Y | N | N | N | Cholecalciferol
 | ESR1: estrogen receptor 1 | 0.37838 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
314 | N | N | N | N | Fulvestrant
 | ESRRB: estrogen-related receptor beta | 0.17308 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
315 | N | N | N | N | Tretinoin
 | ESR2: estrogen receptor 2 (ER beta) | 0.10526 | Estradiol
 | 0.16853 | RXRA: retinoid X receptor, alpha |
316 | N | N | N | N | Fenofibrate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.10417 | Cholecalciferol
 | 0.16326 | PPARA: peroxisome proliferator-activated receptor alpha |
317 | N | N | N | N | Dihydrotachysterol
 | AR: androgen receptor | 0.35897 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
318 | N | N | N | N | Phenobarbital
 | ESRRG: estrogen-related receptor gamma | 0.23333 | Diethylstilbestrol
 | 0.16198 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
319 | N | N | N | N | Fenofibrate
 | RARA: retinoic acid receptor, alpha | 0.42857 | Tazarotene
 | 0.20153 | PPARA: peroxisome proliferator-activated receptor alpha |
320 | N | N | N | N | Etretinate
 | ESRRG: estrogen-related receptor gamma | 0.17949 | Diethylstilbestrol
 | 0.25042 | RXRA: retinoid X receptor, alpha |
321 | N | N | N | N | Fenofibrate
 | ESR2: estrogen receptor 2 (ER beta) | 0.45161 | Diethylstilbestrol
 | 0.096117 | PPARA: peroxisome proliferator-activated receptor alpha |
322 | N | N | N | N | Butamben
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.076923 | Cholecalciferol
 | 0.35863 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
323 | N | N | N | N | Fenofibrate
 | ESRRG: estrogen-related receptor gamma | 0.45161 | Diethylstilbestrol
 | 0.14241 | PPARA: peroxisome proliferator-activated receptor alpha |
324 | N | N | N | N | Clofibrate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.23077 | Mifepristone
 | 0.077024 | PPARA: peroxisome proliferator-activated receptor alpha |
325 | N | N | N | N | Tretinoin
 | PGR: progesterone receptor | 0.19048 | Medroxyprogesterone acetate
 | 0.10416 | RXRA: retinoid X receptor, alpha |
326 | N | N | N | N | Raloxifene hydrochloride
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.27624 | Telmisartan
 | 0.10925 | ESR1: estrogen receptor 1 |
327 | N | N | N | N | Cholesterol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.095238 | Palmitic acid
 | 0.097709 | RORA: RAR-related orphan receptor A |
328 | N | N | N | N | Chenodiol
 | RORC: RAR-related orphan receptor C | 0.21951 | Tretinoin
 | 0.10827 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
329 | N | N | N | N | Budesonide
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.31111 | Cholecalciferol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
330 | N | N | N | N | Mifepristone
 | RARA: retinoic acid receptor, alpha | 0.23913 | Tazarotene
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
331 | N | N | N | N | Medroxyprogesterone acetate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.35714 | Ergocalciferol
 | 0.060029 | PGR: progesterone receptor |
332 | N | N | N | N | Etretinate
 | ESR2: estrogen receptor 2 (ER beta) | 0.17949 | Diethylstilbestrol
 | 0.16853 | RXRA: retinoid X receptor, alpha |
333 | N | N | N | N | Imatinib mesylate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.16092 | Rifampin
 | 0.13841 | RORA: RAR-related orphan receptor A |
334 | N | N | N | N | Medroxyprogesterone acetate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.54546 | Pregnenolone
 | 0.066330 | PGR: progesterone receptor |
335 | N | N | N | N | Rifampin
 | RORA: RAR-related orphan receptor A | 0.20833 | Cholesterol
 | 0.13841 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
336 | N | N | N | N | Fulvestrant
 | AR: androgen receptor | 0.29091 | Nandrolone phenpropionate
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
337 | N | N | N | N | Dienestrol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.29268 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
338 | N | N | N | N | Rifampin
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10843 | Rosiglitazone maleate
 | 0.16215 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
339 | N | N | N | N | Phenobarbital
 | PGR: progesterone receptor | 0.19512 | Mifepristone
 | 0.092601 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
340 | N | N | N | N | Estramustine
 | ESRRB: estrogen-related receptor beta | 0.19512 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
341 | N | N | N | N | Dienestrol
 | AR: androgen receptor | 0.32432 | Bicalutamide
 | 0.11924 | ESR1: estrogen receptor 1 |
342 | N | N | N | N | Clofibrate
 | RARG: retinoic acid receptor, gamma | 0.41379 | Tazarotene
 | 0.20327 | PPARA: peroxisome proliferator-activated receptor alpha |
343 | N | N | N | N | Fenofibrate
 | ESRRB: estrogen-related receptor beta | 0.45161 | Diethylstilbestrol
 | 0.12375 | PPARA: peroxisome proliferator-activated receptor alpha |
344 | N | N | N | N | Mifepristone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.35556 | Dihydrotachysterol
 | 0.076190 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
345 | N | N | N | N | Rifampin
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.19178 | Chenodiol
 | 0.18905 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
346 | N | N | N | N | Eplerenone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.34884 | Chenodiol
 | 0.085591 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
347 | N | N | N | N | Rifampin
 | RARA: retinoic acid receptor, alpha | 0.19718 | Etretinate
 | 0.16725 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
348 | N | N | N | N | Mifepristone
 | RORB: RAR-related orphan receptor B | 0.23913 | Tazarotene
 | 0.071358 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
349 | N | N | N | N | Clomiphene citrate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.28846 | Fenofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
350 | N | N | N | N | Tazarotene
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.23913 | Mifepristone
 | 0.11451 | RXRA: retinoid X receptor, alpha |
351 | N | N | N | N | Clofibrate
 | RXRA: retinoid X receptor, alpha | 0.41379 | Tazarotene
 | 0.17514 | PPARA: peroxisome proliferator-activated receptor alpha |
352 | N | N | N | N | Clofibrate
 | RXRG: retinoid X receptor, gamma | 0.41379 | Tazarotene
 | 0.032006 | PPARA: peroxisome proliferator-activated receptor alpha |
353 | N | N | N | N | Ethinyl estradiol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.45946 | Mifepristone
 | 0.13105 | ESR1: estrogen receptor 1 |
354 | N | N | N | N | Palmitic acid
 | ESRRB: estrogen-related receptor beta | 0.085714 | Diethylstilbestrol
 | 0.19080 | HNF4G: hepatocyte nuclear factor 4, gamma |
355 | N | N | N | N | Rosiglitazone maleate
 | RORA: RAR-related orphan receptor A | 0.17188 | Imatinib mesylate
 | 0.17144 | PPARG: peroxisome proliferator-activated receptor gamma |
356 | N | N | N | N | Telmisartan
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.080645 | Cholecalciferol
 | 0.18238 | PPARG: peroxisome proliferator-activated receptor gamma |
357 | N | N | N | N | Dydrogesterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Cholecalciferol
 | 0.060029 | PGR: progesterone receptor |
358 | N | N | N | N | Palmitic acid
 | ESRRA: estrogen-related receptor alpha | 0.085714 | Diethylstilbestrol
 | 0.18497 | HNF4G: hepatocyte nuclear factor 4, gamma |
359 | N | N | N | N | Dydrogesterone
 | RORA: RAR-related orphan receptor A | 0.50000 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
360 | N | N | N | N | Palmitic acid
 | ESRRG: estrogen-related receptor gamma | 0.085714 | Diethylstilbestrol
 | 0.19965 | HNF4G: hepatocyte nuclear factor 4, gamma |
361 | N | N | N | N | Nandrolone phenpropionate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.39474 | Pregnenolone
 | 0.064846 | AR: androgen receptor |
362 | N | N | N | N | Palmitic acid
 | RORC: RAR-related orphan receptor C | 0.11111 | Tretinoin
 | 0.10208 | HNF4G: hepatocyte nuclear factor 4, gamma |
363 | N | N | N | N | Ethynodiol diacetate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.42500 | Spironolactone
 | 0.23099 | PGR: progesterone receptor |
364 | N | N | N | N | Dihydrotachysterol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.35556 | Mifepristone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
365 | N | N | N | N | Chenodiol
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Estradiol
 | 0.12692 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
366 | N | N | N | N | Ergocalciferol
 | PGR: progesterone receptor | 0.36842 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
367 | N | N | N | N | Telmisartan
 | AR: androgen receptor | 0.23636 | Bicalutamide
 | 0.063846 | PPARG: peroxisome proliferator-activated receptor gamma |
368 | N | N | N | N | Mometasone furoate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.22449 | Fenofibrate
 | 0.059277 | PGR: progesterone receptor |
369 | N | N | N | N | Rosiglitazone maleate
 | RARA: retinoic acid receptor, alpha | 0.26087 | Tazarotene
 | 0.19466 | PPARG: peroxisome proliferator-activated receptor gamma |
370 | N | N | N | N | Dihydrotachysterol
 | ESR1: estrogen receptor 1 | 0.35897 | Fluoxymesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
371 | N | N | N | N | Etretinate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.16071 | Telmisartan
 | 0.20203 | RARB: retinoic acid receptor, beta |
372 | N | N | N | N | Mifepristone
 | RARB: retinoic acid receptor, beta | 0.23913 | Tazarotene
 | 0.096751 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
373 | N | N | N | N | Mifepristone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.23077 | Clofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
374 | N | N | N | N | Etretinate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.21212 | Butamben
 | 0.17437 | RARB: retinoic acid receptor, beta |
375 | N | N | N | N | Chenodiol
 | RARA: retinoic acid receptor, alpha | 0.21951 | Tretinoin
 | 0.18904 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
376 | N | N | N | N | Estradiol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.29730 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
377 | N | N | N | N | Etretinate
 | ESRRA: estrogen-related receptor alpha | 0.17949 | Diethylstilbestrol
 | 0.23672 | RXRA: retinoid X receptor, alpha |
378 | N | N | N | N | Ethynodiol diacetate
 | RXRA: retinoid X receptor, alpha | 0.20455 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
379 | N | N | N | N | Mifepristone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.27660 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
380 | N | N | N | N | Mifepristone
 | RORC: RAR-related orphan receptor C | 0.17391 | Tretinoin
 | 0.064847 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
381 | N | N | N | N | Calcitriol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.33333 | Hydrocortisone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
382 | N | N | N | N | Clomiphene citrate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.20000 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
383 | N | N | N | N | Palmitic acid
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.088889 | Budesonide
 | 0.10292 | HNF4G: hepatocyte nuclear factor 4, gamma |
384 | N | N | N | N | Loteprednol etabonate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.37500 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
385 | N | N | N | N | Butamben
 | ESRRA: estrogen-related receptor alpha | 0.36000 | Diethylstilbestrol
 | 0.12402 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
386 | N | N | N | N | Clomiphene citrate
 | PGR: progesterone receptor | 0.13846 | Mifepristone
 | 0.12952 | ESR1: estrogen receptor 1 |
387 | N | N | N | N | Loteprednol etabonate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.20000 | Clofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
388 | N | N | N | N | Diethylstilbestrol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.086957 | Calcitriol
 | 0.14277 | ESRRG: estrogen-related receptor gamma |
389 | N | N | N | N | Telmisartan
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.14286 | Phenobarbital
 | 0.12510 | PPARG: peroxisome proliferator-activated receptor gamma |
390 | N | N | N | N | Oxandrolone
 | RORA: RAR-related orphan receptor A | 0.47059 | Cholesterol
 | 0.055679 | AR: androgen receptor |
391 | N | N | N | N | Testosterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.36111 | Cholecalciferol
 | 0.067869 | AR: androgen receptor |
392 | N | N | N | N | Clofibrate
 | RXRB: retinoid X receptor, beta | 0.41379 | Tazarotene
 | 0.14777 | PPARA: peroxisome proliferator-activated receptor alpha |
393 | N | N | N | N | Ethynodiol diacetate
 | RARA: retinoic acid receptor, alpha | 0.20455 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
394 | N | N | N | N | Palmitic acid
 | ESR2: estrogen receptor 2 (ER beta) | 0.28261 | Fulvestrant
 | 0.14814 | HNF4G: hepatocyte nuclear factor 4, gamma |
395 | N | N | N | N | Fluoxymesterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.36842 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
396 | N | N | N | N | Nilutamide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.22222 | Rosiglitazone maleate
 | 0.063846 | AR: androgen receptor |
397 | N | N | N | N | Fenofibrate
 | ESRRA: estrogen-related receptor alpha | 0.45161 | Diethylstilbestrol
 | 0.11006 | PPARA: peroxisome proliferator-activated receptor alpha |
398 | N | N | N | N | Clofibrate
 | RORA: RAR-related orphan receptor A | 0.18367 | Imatinib mesylate
 | 0.16545 | PPARA: peroxisome proliferator-activated receptor alpha |
399 | N | N | N | N | Fulvestrant
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26786 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
400 | N | N | N | N | Clofibrate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.062500 | Palmitic acid
 | 0.13213 | PPARA: peroxisome proliferator-activated receptor alpha |
401 | N | N | N | N | Mifepristone
 | RORA: RAR-related orphan receptor A | 0.36364 | Cholesterol
 | 0.061072 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
402 | N | N | N | N | Eplerenone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.12195 | Clofibrate
 | 0.069941 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
403 | N | N | N | N | Telmisartan
 | RARA: retinoic acid receptor, alpha | 0.23077 | Tazarotene
 | 0.19466 | PPARG: peroxisome proliferator-activated receptor gamma |
404 | N | N | N | N | Eplerenone
 | RORA: RAR-related orphan receptor A | 0.34884 | Cholesterol
 | 0.061072 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
405 | N | N | N | N | Estramustine
 | RXRA: retinoid X receptor, alpha | 0.28571 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
406 | N | N | N | N | Calcitriol
 | AR: androgen receptor | 0.35000 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
407 | N | N | N | N | Cholecalciferol
 | AR: androgen receptor | 0.36842 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
408 | N | N | N | N | Dienestrol
 | PGR: progesterone receptor | 0.20930 | Mifepristone
 | 0.12952 | ESR1: estrogen receptor 1 |
409 | N | N | N | N | Butamben
 | ESRRB: estrogen-related receptor beta | 0.36000 | Diethylstilbestrol
 | 0.11252 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
410 | N | N | N | N | Ethynodiol diacetate
 | RXRB: retinoid X receptor, beta | 0.20455 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
411 | N | N | N | N | Ethinyl estradiol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26829 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
412 | N | N | N | N | Hydrocortisone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.42105 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
413 | N | N | N | N | Bicalutamide
 | RORA: RAR-related orphan receptor A | 0.32722 | Imatinib mesylate
 | 0.055679 | AR: androgen receptor |
414 | N | N | N | N | Norethindrone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.31579 | Cholecalciferol
 | 0.060029 | PGR: progesterone receptor |
415 | N | N | N | N | Cholesterol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10417 | Fenofibrate
 | 0.16545 | RORA: RAR-related orphan receptor A |
416 | N | N | N | N | Ergocalciferol
 | ESR1: estrogen receptor 1 | 0.36842 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
417 | N | N | N | N | Fenofibrate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.21277 | Mifepristone
 | 0.077024 | PPARA: peroxisome proliferator-activated receptor alpha |
418 | N | N | N | N | Hydrocortisone
 | RORA: RAR-related orphan receptor A | 0.45946 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
419 | N | N | N | N | Rifampin
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.15069 | Fenofibrate
 | 0.14611 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
420 | N | N | N | N | Budesonide
 | RORA: RAR-related orphan receptor A | 0.37209 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
421 | N | N | N | N | Dihydrotachysterol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.35556 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
422 | N | N | N | N | Desogestrel
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.48485 | Hydrocortisone
 | 0.25727 | PGR: progesterone receptor |
423 | N | Y | N | N | Flutamide
 | ESR1: estrogen receptor 1 | 0.23077 | Estramustine
 | 0.11924 | AR: androgen receptor |
424 | N | N | N | N | Medroxyprogesterone acetate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.17778 | Fenofibrate
 | 0.059277 | PGR: progesterone receptor |
425 | N | N | N | N | Estramustine
 | RXRB: retinoid X receptor, beta | 0.28571 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
426 | N | N | N | N | Amcinonide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.15556 | Clofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
427 | Y | Y | N | N | Fulvestrant
 | PGR: progesterone receptor | 0.23729 | Mifepristone
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
428 | N | N | N | N | Spironolactone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.28889 | Dihydrotachysterol
 | 0.076190 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
429 | N | N | N | N | Medroxyprogesterone acetate
 | RARA: retinoic acid receptor, alpha | 0.19048 | Tretinoin
 | 0.084891 | PGR: progesterone receptor |
430 | N | N | N | N | Butamben
 | ESRRG: estrogen-related receptor gamma | 0.36000 | Diethylstilbestrol
 | 0.11500 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
431 | N | N | N | N | Cholecalciferol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.33333 | Mifepristone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
432 | N | N | N | N | Spironolactone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.095238 | Phenobarbital
 | 0.094019 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
433 | N | N | N | N | Medroxyprogesterone acetate
 | RORA: RAR-related orphan receptor A | 0.47368 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
434 | N | N | N | N | Imatinib mesylate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.11321 | Phenobarbital
 | 0.10498 | RORA: RAR-related orphan receptor A |
435 | N | N | N | N | Phenobarbital
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.054054 | Tretinoin
 | 0.028787 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
436 | N | N | N | N | Clofibrate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.095238 | Calcitriol
 | 0.16326 | PPARA: peroxisome proliferator-activated receptor alpha |
437 | N | N | N | N | Dihydrotachysterol
 | RORA: RAR-related orphan receptor A | 0.46250 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
438 | N | N | N | N | Estrone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26316 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
439 | N | N | N | N | Etretinate
 | ESRRB: estrogen-related receptor beta | 0.17949 | Diethylstilbestrol
 | 0.23259 | RXRA: retinoid X receptor, alpha |
440 | N | N | N | N | Imatinib mesylate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.034483 | Palmitic acid
 | 0.097709 | RORA: RAR-related orphan receptor A |
441 | N | N | N | N | Etretinate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.080000 | Chenodiol
 | 0.19755 | RARB: retinoic acid receptor, beta |
442 | N | N | N | N | Cholesterol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.080645 | Telmisartan
 | 0.17144 | RORA: RAR-related orphan receptor A |
443 | N | N | N | N | Cholecalciferol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10909 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
444 | N | N | N | N | Testosterone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.62963 | Pregnenolone
 | 0.064846 | AR: androgen receptor |
445 | N | N | N | N | Rosiglitazone maleate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.18182 | Mifepristone
 | 0.068035 | PPARG: peroxisome proliferator-activated receptor gamma |
446 | N | N | N | N | Nilutamide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.22581 | Clofibrate
 | 0.061430 | AR: androgen receptor |
447 | N | N | N | N | Cholecalciferol
 | PGR: progesterone receptor | 0.37838 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
448 | N | N | N | N | Ergocalciferol
 | AR: androgen receptor | 0.35897 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
449 | N | N | N | N | Imatinib mesylate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.21311 | Mifepristone
 | 0.061022 | RORA: RAR-related orphan receptor A |
450 | Y | N | N | N | Estradiol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.40541 | Mifepristone
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
451 | N | N | N | N | Nandrolone phenpropionate
 | ESR2: estrogen receptor 2 (ER beta) | 0.47059 | Estradiol
 | 0.11996 | AR: androgen receptor |
452 | N | N | N | N | Pregnenolone
 | RORC: RAR-related orphan receptor C | 0.18421 | Tretinoin
 | 0.15608 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
453 | N | N | N | N | Clofibrate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.23077 | Mifepristone
 | 0.069941 | PPARA: peroxisome proliferator-activated receptor alpha |
454 | N | N | N | N | Nandrolone phenpropionate
 | RORA: RAR-related orphan receptor A | 0.41463 | Cholesterol
 | 0.055679 | AR: androgen receptor |
455 | N | N | N | N | Oxandrolone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.55172 | Pregnenolone
 | 0.064846 | AR: androgen receptor |
456 | N | N | N | N | Mifepristone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.17391 | Tretinoin
 | 0.020772 | PGR: progesterone receptor |
457 | N | N | N | N | Chenodiol
 | ESRRG: estrogen-related receptor gamma | 0.090909 | Diethylstilbestrol
 | 0.15388 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
458 | N | N | N | N | Imatinib mesylate
 | RARA: retinoic acid receptor, alpha | 0.31372 | Tazarotene
 | 0.15182 | RORA: RAR-related orphan receptor A |
459 | N | N | N | N | Butamben
 | RARA: retinoic acid receptor, alpha | 0.34483 | Tazarotene
 | 0.16725 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
460 | N | N | N | N | Isotretinoin
 | AR: androgen receptor | 0.17949 | Fluoxymesterone
 | 0.087217 | RARA: retinoic acid receptor, alpha |
461 | N | N | N | N | Progesterone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.76923 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
462 | N | N | N | N | Chenodiol
 | ESRRB: estrogen-related receptor beta | 0.090909 | Diethylstilbestrol
 | 0.14022 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
463 | N | N | N | N | Tretinoin
 | AR: androgen receptor | 0.17949 | Fluoxymesterone
 | 0.10468 | RXRA: retinoid X receptor, alpha |
464 | N | N | N | N | Ethynodiol diacetate
 | RARG: retinoic acid receptor, gamma | 0.20455 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
465 | N | N | N | N | Imatinib mesylate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.12903 | Chenodiol
 | 0.13581 | RORA: RAR-related orphan receptor A |
466 | N | N | N | N | Tretinoin
 | ESR1: estrogen receptor 1 | 0.18421 | Progesterone
 | 0.18294 | RXRA: retinoid X receptor, alpha |
467 | N | N | N | N | Butamben
 | AR: androgen receptor | 0.25714 | Nandrolone phenpropionate
 | 0.064846 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
468 | N | N | N | N | Estrone sodium sulfate
 | RORA: RAR-related orphan receptor A | 0.26415 | Imatinib mesylate
 | 0.085339 | ESR1: estrogen receptor 1 |
469 | N | N | N | N | Testosterone
 | RORA: RAR-related orphan receptor A | 0.53125 | Cholesterol
 | 0.055679 | AR: androgen receptor |
470 | N | N | N | N | Etretinate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.10256 | Phenobarbital
 | 0.18237 | RARG: retinoic acid receptor, gamma |
471 | N | N | N | N | Nilutamide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.20000 | Mifepristone
 | 0.20529 | AR: androgen receptor |
472 | N | N | N | N | Calcitriol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10526 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
473 | N | N | N | N | Spironolactone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.021739 | Palmitic acid
 | 0.082312 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
474 | N | N | N | N | Eplerenone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.093023 | Phenobarbital
 | 0.094019 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
475 | N | N | N | N | Chenodiol
 | ESRRA: estrogen-related receptor alpha | 0.090909 | Diethylstilbestrol
 | 0.13665 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
476 | N | N | N | N | Mifepristone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.020408 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
477 | N | N | N | N | Ethynodiol diacetate
 | RARB: retinoic acid receptor, beta | 0.20455 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
478 | N | N | N | N | Palmitic acid
 | RARA: retinoic acid receptor, alpha | 0.11111 | Tretinoin
 | 0.17474 | HNF4G: hepatocyte nuclear factor 4, gamma |
479 | N | N | N | N | Calcitriol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.044444 | Phenobarbital
 | 0.27216 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
480 | N | N | N | N | Fenofibrate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.081633 | Chenodiol
 | 0.15232 | PPARA: peroxisome proliferator-activated receptor alpha |
481 | N | N | N | N | Imatinib mesylate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.21311 | Mifepristone
 | 0.061072 | RORA: RAR-related orphan receptor A |
482 | N | N | N | N | Clofibrate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.073171 | Chenodiol
 | 0.15232 | PPARA: peroxisome proliferator-activated receptor alpha |
483 | N | N | N | N | Fenofibrate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.16667 | Phenobarbital
 | 0.12527 | PPARA: peroxisome proliferator-activated receptor alpha |
484 | N | N | N | N | Cholecalciferol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.046512 | Phenobarbital
 | 0.27216 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
485 | N | N | N | N | Spironolactone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.080000 | Fenofibrate
 | 0.069941 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
486 | N | N | N | N | Loteprednol etabonate
 | RARA: retinoic acid receptor, alpha | 0.18750 | Tazarotene
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
487 | N | N | N | N | Estramustine
 | RARA: retinoic acid receptor, alpha | 0.28571 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
488 | N | N | N | N | Calcitriol
 | PGR: progesterone receptor | 0.35897 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
489 | N | N | N | N | Palmitic acid
 | RXRA: retinoid X receptor, alpha | 0.11111 | Tretinoin
 | 0.30016 | HNF4G: hepatocyte nuclear factor 4, gamma |
490 | N | N | N | N | Telmisartan
 | ESR2: estrogen receptor 2 (ER beta) | 0.28261 | Diethylstilbestrol
 | 0.094479 | PPARG: peroxisome proliferator-activated receptor gamma |
491 | N | N | N | N | Fenofibrate
 | RARB: retinoic acid receptor, beta | 0.42857 | Tazarotene
 | 0.21233 | PPARA: peroxisome proliferator-activated receptor alpha |
492 | N | N | N | N | Estrone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.34375 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
493 | N | N | N | N | Ergocalciferol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.045455 | Phenobarbital
 | 0.27216 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
494 | N | N | N | N | Spironolactone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.068966 | Rosiglitazone maleate
 | 0.066795 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
495 | N | N | N | N | Phenobarbital
 | RORC: RAR-related orphan receptor C | 0.054054 | Tretinoin
 | 0.10540 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
496 | N | N | N | N | Paricalcitol
 | AR: androgen receptor | 0.36842 | Oxandrolone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
497 | N | N | N | N | Mifepristone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.18182 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
498 | N | N | N | N | Rosiglitazone maleate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.18182 | Mifepristone
 | 0.066795 | PPARG: peroxisome proliferator-activated receptor gamma |
499 | N | N | N | N | Fenofibrate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.21277 | Mifepristone
 | 0.069941 | PPARA: peroxisome proliferator-activated receptor alpha |
500 | N | N | N | N | Paricalcitol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.044444 | Phenobarbital
 | 0.27216 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
501 | N | N | N | N | Budesonide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.088889 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
502 | N | N | N | N | Nandrolone phenpropionate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.31818 | Cholecalciferol
 | 0.067869 | AR: androgen receptor |
503 | N | N | N | N | Butamben
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.076923 | Chenodiol
 | 0.18905 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
504 | N | N | N | N | Dihydrotachysterol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.045455 | Phenobarbital
 | 0.27216 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
505 | N | N | N | N | Chenodiol
 | RORB: RAR-related orphan receptor B | 0.21951 | Tretinoin
 | 0.14486 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
506 | N | N | N | N | Fulvestrant
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.27778 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
507 | N | N | N | N | Fulvestrant
 | RORA: RAR-related orphan receptor A | 0.27778 | Cholesterol
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
508 | N | N | N | N | Flutamide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.22222 | Butamben
 | 0.064846 | AR: androgen receptor |
509 | N | N | N | N | Eplerenone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.021277 | Palmitic acid
 | 0.082312 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
510 | N | N | N | N | Palmitic acid
 | RXRB: retinoid X receptor, beta | 0.11111 | Tretinoin
 | 0.27886 | HNF4G: hepatocyte nuclear factor 4, gamma |
511 | N | N | N | N | Desogestrel
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.41026 | Mifepristone
 | 0.23099 | PGR: progesterone receptor |
512 | N | N | N | N | Rifampin
 | AR: androgen receptor | 0.22059 | Fluoxymesterone
 | 0.064846 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
513 | N | N | N | N | Loteprednol etabonate
 | RORA: RAR-related orphan receptor A | 0.36364 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
514 | N | N | N | N | Bicalutamide
 | ESRRA: estrogen-related receptor alpha | 0.36111 | Diethylstilbestrol
 | 0.12419 | AR: androgen receptor |
515 | N | N | N | N | Fluoxymesterone
 | RXRA: retinoid X receptor, alpha | 0.17949 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
516 | N | N | N | N | Progesterone
 | RXRA: retinoid X receptor, alpha | 0.18421 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
517 | N | N | N | N | Raloxifene hydrochloride
 | PGR: progesterone receptor | 0.19643 | Mifepristone
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
518 | N | N | N | N | Nandrolone phenpropionate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.24324 | Clofibrate
 | 0.061430 | AR: androgen receptor |
519 | N | N | N | N | Mometasone furoate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.15254 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
520 | N | N | N | N | Mometasone furoate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.31818 | Pregnenolone
 | 0.066330 | PGR: progesterone receptor |
521 | N | N | N | N | Fenofibrate
 | RORB: RAR-related orphan receptor B | 0.42857 | Tazarotene
 | 0.17773 | PPARA: peroxisome proliferator-activated receptor alpha |
522 | N | N | N | N | Calcitriol
 | ESR2: estrogen receptor 2 (ER beta) | 0.28205 | Estradiol
 | 0.10255 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
523 | N | N | N | N | Ergocalciferol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.39024 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
524 | N | N | N | N | Hydrocortisone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.33333 | Calcitriol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
525 | N | N | N | N | Raloxifene hydrochloride
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.30435 | Fenofibrate
 | 0.096117 | ESR2: estrogen receptor 2 (ER beta) |
526 | N | N | N | N | Eplerenone
 | RARA: retinoic acid receptor, alpha | 0.17021 | Tazarotene
 | 0.087093 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
527 | N | N | N | N | Budesonide
 | ESR2: estrogen receptor 2 (ER beta) | 0.27660 | Estramustine
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
528 | N | N | N | N | Dihydrotachysterol
 | RARG: retinoic acid receptor, gamma | 0.34210 | Tretinoin
 | 0.18311 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
529 | N | N | N | N | Norethindrone
 | RORA: RAR-related orphan receptor A | 0.42857 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
530 | N | N | N | N | Bicalutamide
 | ESRRG: estrogen-related receptor gamma | 0.36111 | Diethylstilbestrol
 | 0.11916 | AR: androgen receptor |
531 | N | N | N | N | Dihydrotachysterol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.37369 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
532 | N | N | N | N | Fenofibrate
 | RARG: retinoic acid receptor, gamma | 0.42857 | Tazarotene
 | 0.20327 | PPARA: peroxisome proliferator-activated receptor alpha |
533 | N | N | Y | N | Ethinyl estradiol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.32353 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
534 | N | N | N | N | Telmisartan
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.14516 | Mifepristone
 | 0.068035 | PPARG: peroxisome proliferator-activated receptor gamma |
535 | N | N | N | N | Telmisartan
 | ESRRG: estrogen-related receptor gamma | 0.28261 | Diethylstilbestrol
 | 0.14244 | PPARG: peroxisome proliferator-activated receptor gamma |
536 | N | N | N | N | Bicalutamide
 | ESRRB: estrogen-related receptor beta | 0.36111 | Diethylstilbestrol
 | 0.11072 | AR: androgen receptor |
537 | N | N | N | N | Spironolactone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15909 | Tretinoin
 | 0.020347 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
538 | N | N | N | N | Estramustine
 | RARB: retinoic acid receptor, beta | 0.28571 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
539 | N | N | N | N | Nilutamide
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.20000 | Mifepristone
 | 0.23366 | AR: androgen receptor |
540 | N | N | N | N | Fenofibrate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.023810 | Palmitic acid
 | 0.13213 | PPARA: peroxisome proliferator-activated receptor alpha |
541 | N | N | N | N | Cholesterol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.046512 | Phenobarbital
 | 0.10498 | RORA: RAR-related orphan receptor A |
542 | N | N | N | N | Imatinib mesylate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.12903 | Cholecalciferol
 | 0.16329 | RORA: RAR-related orphan receptor A |
543 | N | N | N | N | Rosiglitazone maleate
 | ESRRG: estrogen-related receptor gamma | 0.29268 | Diethylstilbestrol
 | 0.14244 | PPARG: peroxisome proliferator-activated receptor gamma |
544 | N | N | N | N | Telmisartan
 | ESRRA: estrogen-related receptor alpha | 0.28261 | Diethylstilbestrol
 | 0.12835 | PPARG: peroxisome proliferator-activated receptor gamma |
545 | N | N | N | N | Rosiglitazone maleate
 | ESRRA: estrogen-related receptor alpha | 0.29268 | Diethylstilbestrol
 | 0.12835 | PPARG: peroxisome proliferator-activated receptor gamma |
546 | N | N | N | N | Eplerenone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.067797 | Rosiglitazone maleate
 | 0.066795 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
547 | N | N | N | N | Isotretinoin
 | PGR: progesterone receptor | 0.19048 | Medroxyprogesterone acetate
 | 0.084891 | RARA: retinoic acid receptor, alpha |
548 | N | N | N | N | Raloxifene hydrochloride
 | RXRA: retinoid X receptor, alpha | 0.30435 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
549 | N | N | N | N | Progesterone
 | RXRB: retinoid X receptor, beta | 0.18421 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
550 | N | N | N | N | Nilutamide
 | RARA: retinoic acid receptor, alpha | 0.20513 | Tazarotene
 | 0.087217 | AR: androgen receptor |
551 | N | N | N | N | Estradiol
 | RXRA: retinoid X receptor, alpha | 0.25000 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
552 | N | N | N | N | Fenofibrate
 | RXRA: retinoid X receptor, alpha | 0.42857 | Tazarotene
 | 0.17514 | PPARA: peroxisome proliferator-activated receptor alpha |
553 | N | N | N | N | Ergocalciferol
 | RARG: retinoic acid receptor, gamma | 0.34210 | Tretinoin
 | 0.18311 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
554 | N | N | N | N | Fenofibrate
 | RXRG: retinoid X receptor, gamma | 0.42857 | Tazarotene
 | 0.032006 | PPARA: peroxisome proliferator-activated receptor alpha |
555 | N | N | N | N | Dihydrotachysterol
 | RARB: retinoic acid receptor, beta | 0.34210 | Tretinoin
 | 0.18029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
556 | N | N | N | N | Paricalcitol
 | PGR: progesterone receptor | 0.35897 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
557 | N | N | N | N | Raloxifene hydrochloride
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.19512 | Butamben
 | 0.095273 | ESR1: estrogen receptor 1 |
558 | N | N | N | N | Estramustine
 | RARG: retinoic acid receptor, gamma | 0.28571 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
559 | N | N | N | N | Testosterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.44118 | Chenodiol
 | 0.081683 | AR: androgen receptor |
560 | N | N | N | N | Ethinyl estradiol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.45946 | Mifepristone
 | 0.12027 | ESR1: estrogen receptor 1 |
561 | N | N | N | N | Ethynodiol diacetate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.32558 | Dihydrotachysterol
 | 0.11238 | ESR1: estrogen receptor 1 |
562 | N | N | N | N | Etretinate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.13725 | Mifepristone
 | 0.11451 | RXRA: retinoid X receptor, alpha |
563 | N | N | N | N | Fluoxymesterone
 | RXRB: retinoid X receptor, beta | 0.17949 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
564 | N | N | N | N | Telmisartan
 | ESRRB: estrogen-related receptor beta | 0.28261 | Diethylstilbestrol
 | 0.12689 | PPARG: peroxisome proliferator-activated receptor gamma |
565 | N | N | N | N | Paricalcitol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10000 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
566 | N | N | N | N | Rosiglitazone maleate
 | ESRRB: estrogen-related receptor beta | 0.29268 | Diethylstilbestrol
 | 0.12689 | PPARG: peroxisome proliferator-activated receptor gamma |
567 | N | N | N | N | Nilutamide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.20000 | Butamben
 | 0.064846 | AR: androgen receptor |
568 | N | N | N | N | Dydrogesterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.41667 | Chenodiol
 | 0.077571 | PGR: progesterone receptor |
569 | N | N | N | N | Raloxifene hydrochloride
 | RARA: retinoic acid receptor, alpha | 0.30435 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
570 | N | N | N | N | Rifampin
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.20270 | Eplerenone
 | 0.075614 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
571 | N | N | N | N | Norethindrone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.50000 | Pregnenolone
 | 0.066330 | PGR: progesterone receptor |
572 | N | N | N | N | Ergocalciferol
 | RARB: retinoic acid receptor, beta | 0.34210 | Tretinoin
 | 0.18029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
573 | N | N | N | N | Bicalutamide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.22857 | Butamben
 | 0.064846 | AR: androgen receptor |
574 | N | N | N | N | Paricalcitol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.33333 | Hydrocortisone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
575 | N | N | N | N | Rifampin
 | RARB: retinoic acid receptor, beta | 0.19718 | Etretinate
 | 0.17437 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
576 | N | N | N | N | Paricalcitol
 | RORA: RAR-related orphan receptor A | 0.43232 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
577 | N | N | N | N | Calcitriol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10000 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
578 | N | N | N | N | Budesonide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.38461 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
579 | N | N | N | N | Ethynodiol diacetate
 | AR: androgen receptor | 0.48718 | Nandrolone phenpropionate
 | 0.25472 | PGR: progesterone receptor |
580 | N | N | N | N | Butamben
 | RXRG: retinoid X receptor, gamma | 0.34483 | Tazarotene
 | 0.048806 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
581 | N | N | N | N | Ethynodiol diacetate
 | RORB: RAR-related orphan receptor B | 0.20455 | Tazarotene
 | 0.090711 | ESR1: estrogen receptor 1 |
582 | N | N | N | N | Amcinonide
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.30612 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
583 | N | N | N | N | Rifampin
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.013158 | Palmitic acid
 | 0.11513 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
584 | N | N | N | N | Estradiol
 | RXRB: retinoid X receptor, beta | 0.25000 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
585 | N | N | Y | N | Estradiol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.38710 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
586 | N | N | N | N | Ethynodiol diacetate
 | RXRG: retinoid X receptor, gamma | 0.20455 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
587 | N | N | N | N | Raloxifene hydrochloride
 | RXRB: retinoid X receptor, beta | 0.30435 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
588 | N | N | N | N | Estrone sodium sulfate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.20455 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
589 | N | N | N | N | Rifampin
 | ESR1: estrogen receptor 1 | 0.22059 | Fluoxymesterone
 | 0.095273 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
590 | N | N | N | N | Isotretinoin
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.18421 | Pregnenolone
 | 0.16725 | RARA: retinoic acid receptor, alpha |
591 | Y | N | N | N | Bicalutamide
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17308 | Mifepristone
 | 0.23366 | AR: androgen receptor |
592 | N | N | N | N | Budesonide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10345 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
593 | N | N | N | N | Mifepristone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.37500 | Pregnenolone
 | 0.075614 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
594 | N | N | N | N | Amcinonide
 | ESR1: estrogen receptor 1 | 0.46342 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
595 | N | N | N | N | Cholecalciferol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.095238 | Palmitic acid
 | 0.11942 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
596 | N | N | N | N | Palmitic acid
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.021739 | Spironolactone
 | 0.082312 | HNF4G: hepatocyte nuclear factor 4, gamma |
597 | N | N | N | N | Phenobarbital
 | RARA: retinoic acid receptor, alpha | 0.16667 | Tazarotene
 | 0.17500 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
598 | N | N | N | N | Rosiglitazone maleate
 | RORB: RAR-related orphan receptor B | 0.26087 | Tazarotene
 | 0.18625 | PPARG: peroxisome proliferator-activated receptor gamma |
599 | N | N | N | N | Flutamide
 | RORA: RAR-related orphan receptor A | 0.22000 | Imatinib mesylate
 | 0.055679 | AR: androgen receptor |
600 | N | N | N | N | Loteprednol etabonate
 | RXRG: retinoid X receptor, gamma | 0.18750 | Tazarotene
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
601 | N | N | N | N | Dienestrol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.25926 | Butamben
 | 0.095273 | ESR1: estrogen receptor 1 |
602 | N | N | N | N | Telmisartan
 | RORC: RAR-related orphan receptor C | 0.10909 | Tretinoin
 | 0.15526 | PPARG: peroxisome proliferator-activated receptor gamma |
603 | N | N | N | N | Palmitic acid
 | AR: androgen receptor | 0.066667 | Nandrolone phenpropionate
 | 0.093100 | HNF4G: hepatocyte nuclear factor 4, gamma |
604 | N | N | N | N | Butamben
 | RARB: retinoic acid receptor, beta | 0.34483 | Tazarotene
 | 0.17437 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
605 | N | N | N | N | Butamben
 | RORA: RAR-related orphan receptor A | 0.14286 | Imatinib mesylate
 | 0.13841 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
606 | N | N | N | N | Rosiglitazone maleate
 | RARB: retinoic acid receptor, beta | 0.26087 | Tazarotene
 | 0.20203 | PPARG: peroxisome proliferator-activated receptor gamma |
607 | N | N | N | N | Telmisartan
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.14516 | Mifepristone
 | 0.066795 | PPARG: peroxisome proliferator-activated receptor gamma |
608 | N | N | N | N | Medroxyprogesterone acetate
 | RXRG: retinoid X receptor, gamma | 0.19048 | Tretinoin
 | 0.035880 | PGR: progesterone receptor |
609 | N | N | N | N | Fenofibrate
 | RXRB: retinoid X receptor, beta | 0.42857 | Tazarotene
 | 0.14777 | PPARA: peroxisome proliferator-activated receptor alpha |
610 | N | N | N | N | Nandrolone phenpropionate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.23684 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
611 | N | N | N | N | Isotretinoin
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10909 | Telmisartan
 | 0.19466 | RARA: retinoic acid receptor, alpha |
612 | N | N | N | N | Etretinate
 | AR: androgen receptor | 0.15385 | Flutamide
 | 0.10468 | RXRA: retinoid X receptor, alpha |
613 | N | N | N | N | Calcitriol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.090909 | Palmitic acid
 | 0.11942 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
614 | N | N | N | N | Norethindrone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.078431 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
615 | N | N | N | N | Progesterone
 | RARA: retinoic acid receptor, alpha | 0.18421 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
616 | N | N | N | N | Flutamide
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.15909 | Mifepristone
 | 0.23366 | AR: androgen receptor |
617 | N | N | N | N | Fluoxymesterone
 | RARA: retinoic acid receptor, alpha | 0.17949 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
618 | N | N | N | N | Rifampin
 | RXRG: retinoid X receptor, gamma | 0.19718 | Etretinate
 | 0.048806 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
619 | N | N | N | N | Levonorgestrel
 | ESRRG: estrogen-related receptor gamma | 0.075000 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
620 | N | N | N | N | Norgestrel
 | ESRRG: estrogen-related receptor gamma | 0.075000 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
621 | N | N | N | N | Eplerenone
 | RXRG: retinoid X receptor, gamma | 0.17021 | Tazarotene
 | 0.035964 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
622 | N | N | N | N | Paricalcitol
 | RARG: retinoic acid receptor, gamma | 0.33333 | Tretinoin
 | 0.18311 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
623 | N | N | N | N | Levonorgestrel
 | ESRRA: estrogen-related receptor alpha | 0.075000 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
624 | N | N | N | N | Norgestrel
 | ESRRA: estrogen-related receptor alpha | 0.075000 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
625 | N | N | N | N | Telmisartan
 | RORB: RAR-related orphan receptor B | 0.23077 | Tazarotene
 | 0.18625 | PPARG: peroxisome proliferator-activated receptor gamma |
626 | N | N | N | N | Pregnenolone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.18421 | Tretinoin
 | 0.035170 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
627 | N | N | N | N | Isotretinoin
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17391 | Mifepristone
 | 0.095668 | RARA: retinoic acid receptor, alpha |
628 | N | N | N | N | Calcitriol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.31915 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
629 | N | N | N | N | Dihydrotachysterol
 | RXRG: retinoid X receptor, gamma | 0.34210 | Tretinoin
 | 0.043160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
630 | N | N | N | N | Ergocalciferol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10204 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
631 | N | N | N | N | Budesonide
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.31111 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
632 | Y | N | N | N | Rosiglitazone maleate
 | RARG: retinoic acid receptor, gamma | 0.26087 | Tazarotene
 | 0.19825 | PPARG: peroxisome proliferator-activated receptor gamma |
633 | N | N | N | N | Mometasone furoate
 | RARA: retinoic acid receptor, alpha | 0.22449 | Tazarotene
 | 0.084891 | PGR: progesterone receptor |
634 | N | N | N | N | Flutamide
 | ESR2: estrogen receptor 2 (ER beta) | 0.23077 | Estramustine
 | 0.11996 | AR: androgen receptor |
635 | N | N | N | N | Cholecalciferol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10417 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
636 | N | N | N | N | Clomiphene citrate
 | RARA: retinoic acid receptor, alpha | 0.21818 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
637 | N | N | N | N | Rifampin
 | PGR: progesterone receptor | 0.25186 | Medroxyprogesterone acetate
 | 0.066330 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
638 | N | N | N | N | Amcinonide
 | RORA: RAR-related orphan receptor A | 0.30612 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
639 | N | N | N | N | Ergocalciferol
 | RORC: RAR-related orphan receptor C | 0.34210 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
640 | N | N | N | N | Dihydrotachysterol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10204 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
641 | N | N | N | N | Clofibrate
 | RORB: RAR-related orphan receptor B | 0.41379 | Tazarotene
 | 0.17773 | PPARA: peroxisome proliferator-activated receptor alpha |
642 | N | N | N | N | Flutamide
 | RARA: retinoic acid receptor, alpha | 0.22222 | Tazarotene
 | 0.087217 | AR: androgen receptor |
643 | N | N | N | N | Loteprednol etabonate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.063830 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
644 | N | N | N | N | Paricalcitol
 | RARB: retinoic acid receptor, beta | 0.33333 | Tretinoin
 | 0.18029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
645 | N | N | N | N | Eplerenone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15556 | Tretinoin
 | 0.020347 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
646 | N | N | N | N | Clofibrate
 | ESRRG: estrogen-related receptor gamma | 0.33333 | Diethylstilbestrol
 | 0.14241 | PPARA: peroxisome proliferator-activated receptor alpha |
647 | N | N | N | N | Raloxifene hydrochloride
 | AR: androgen receptor | 0.33333 | Bicalutamide
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
648 | N | N | N | N | Cholesterol
 | RARA: retinoic acid receptor, alpha | 0.19048 | Tretinoin
 | 0.15182 | RORA: RAR-related orphan receptor A |
649 | N | N | N | N | Dihydrotachysterol
 | RXRA: retinoid X receptor, alpha | 0.34210 | Tretinoin
 | 0.13066 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
650 | N | N | N | N | Imatinib mesylate
 | ESRRA: estrogen-related receptor alpha | 0.25265 | Diethylstilbestrol
 | 0.094996 | RORA: RAR-related orphan receptor A |
651 | N | N | N | N | Clomiphene citrate
 | RORA: RAR-related orphan receptor A | 0.22634 | Imatinib mesylate
 | 0.085339 | ESR1: estrogen receptor 1 |
652 | N | N | N | N | Estradiol
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
653 | N | N | N | N | Chenodiol
 | RARB: retinoic acid receptor, beta | 0.21951 | Tretinoin
 | 0.19755 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
654 | N | N | N | N | Estradiol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.33333 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
655 | N | N | N | N | Estrone sodium sulfate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.26316 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
656 | N | N | N | N | Clofibrate
 | PGR: progesterone receptor | 0.23077 | Mifepristone
 | 0.059277 | PPARA: peroxisome proliferator-activated receptor alpha |
657 | N | N | N | N | Flutamide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.15909 | Mifepristone
 | 0.20529 | AR: androgen receptor |
658 | N | N | N | N | Raloxifene hydrochloride
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.19643 | Mifepristone
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
659 | N | N | N | N | Hydrocortisone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.047619 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
660 | N | N | N | N | Dihydrotachysterol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.068966 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
661 | N | N | N | N | Hydrocortisone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.10256 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
662 | N | N | N | N | Ergocalciferol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.068966 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
663 | N | N | N | N | Rosiglitazone maleate
 | RORC: RAR-related orphan receptor C | 0.10000 | Tretinoin
 | 0.15526 | PPARG: peroxisome proliferator-activated receptor gamma |
664 | N | N | N | N | Fenofibrate
 | PGR: progesterone receptor | 0.22449 | Mometasone furoate
 | 0.059277 | PPARA: peroxisome proliferator-activated receptor alpha |
665 | N | N | N | N | Clofibrate
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Diethylstilbestrol
 | 0.096117 | PPARA: peroxisome proliferator-activated receptor alpha |
666 | N | N | N | N | Ergocalciferol
 | RXRG: retinoid X receptor, gamma | 0.34210 | Tretinoin
 | 0.043160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
667 | N | N | N | N | Estramustine
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.32609 | Mifepristone
 | 0.12278 | ESR2: estrogen receptor 2 (ER beta) |
668 | N | N | N | N | Progesterone
 | RORA: RAR-related orphan receptor A | 0.54546 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
669 | N | N | N | N | Estrone sodium sulfate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.20833 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
670 | N | N | N | N | Loteprednol etabonate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.27660 | Cholecalciferol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
671 | N | N | N | N | Imatinib mesylate
 | ESRRB: estrogen-related receptor beta | 0.25265 | Diethylstilbestrol
 | 0.091736 | RORA: RAR-related orphan receptor A |
672 | N | N | N | N | Estrone sodium sulfate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.20588 | Clofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
673 | N | N | N | N | Cholecalciferol
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
674 | N | N | N | N | Rosiglitazone maleate
 | ESR2: estrogen receptor 2 (ER beta) | 0.29268 | Diethylstilbestrol
 | 0.094479 | PPARG: peroxisome proliferator-activated receptor gamma |
675 | N | N | N | N | Medroxyprogesterone acetate
 | RXRB: retinoid X receptor, beta | 0.19048 | Tretinoin
 | 0.096643 | PGR: progesterone receptor |
676 | N | N | N | N | Estradiol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.40541 | Mifepristone
 | 0.12278 | ESR2: estrogen receptor 2 (ER beta) |
677 | N | N | N | N | Estrone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.40541 | Mifepristone
 | 0.13105 | ESR1: estrogen receptor 1 |
678 | N | N | N | N | Progesterone
 | RARG: retinoic acid receptor, gamma | 0.18421 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
679 | N | N | N | N | Estramustine
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26667 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
680 | N | N | N | N | Levonorgestrel
 | RXRA: retinoid X receptor, alpha | 0.12500 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
681 | N | N | N | N | Norgestrel
 | RXRA: retinoid X receptor, alpha | 0.12500 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
682 | N | N | N | N | Estrone
 | RORA: RAR-related orphan receptor A | 0.29730 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
683 | Y | N | N | N | Rosiglitazone maleate
 | RXRA: retinoid X receptor, alpha | 0.26087 | Tazarotene
 | 0.17057 | PPARG: peroxisome proliferator-activated receptor gamma |
684 | N | N | N | N | Estrone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.23333 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
685 | N | N | N | N | Clomiphene citrate
 | AR: androgen receptor | 0.24561 | Bicalutamide
 | 0.11924 | ESR1: estrogen receptor 1 |
686 | N | N | N | N | Nandrolone phenpropionate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.18868 | Rosiglitazone maleate
 | 0.063846 | AR: androgen receptor |
687 | N | N | N | N | Pregnenolone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025000 | Palmitic acid
 | 0.11513 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
688 | N | N | N | N | Fluoxymesterone
 | RARG: retinoic acid receptor, gamma | 0.17949 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
689 | N | N | N | N | Nandrolone phenpropionate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.34884 | Chenodiol
 | 0.081683 | AR: androgen receptor |
690 | N | N | N | N | Spironolactone
 | RORC: RAR-related orphan receptor C | 0.15909 | Tretinoin
 | 0.064847 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
691 | N | N | N | N | Rifampin
 | RORC: RAR-related orphan receptor C | 0.12500 | Tretinoin
 | 0.15608 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
692 | N | N | N | N | Mometasone furoate
 | ESR2: estrogen receptor 2 (ER beta) | 0.36170 | Estramustine
 | 0.13120 | PGR: progesterone receptor |
693 | N | N | N | N | Medroxyprogesterone acetate
 | RXRA: retinoid X receptor, alpha | 0.19048 | Tretinoin
 | 0.10416 | PGR: progesterone receptor |
694 | N | N | N | N | Ergocalciferol
 | RXRA: retinoid X receptor, alpha | 0.34210 | Tretinoin
 | 0.13066 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
695 | N | N | N | N | Loteprednol etabonate
 | RXRA: retinoid X receptor, alpha | 0.18750 | Tazarotene
 | 0.11451 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
696 | N | N | N | N | Levonorgestrel
 | ESRRB: estrogen-related receptor beta | 0.075000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
697 | N | N | N | N | Norgestrel
 | ESRRB: estrogen-related receptor beta | 0.075000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
698 | N | N | N | N | Rifampin
 | RARG: retinoic acid receptor, gamma | 0.19718 | Etretinate
 | 0.16039 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
699 | N | N | N | N | Etretinate
 | PGR: progesterone receptor | 0.14894 | Medroxyprogesterone acetate
 | 0.10416 | RXRA: retinoid X receptor, alpha |
700 | N | N | N | N | Dydrogesterone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.076923 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
701 | N | N | N | N | Amcinonide
 | RARA: retinoic acid receptor, alpha | 0.15094 | Tazarotene
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
702 | N | N | N | N | Desogestrel
 | ESRRA: estrogen-related receptor alpha | 0.075000 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
703 | N | N | N | N | Isotretinoin
 | ESR1: estrogen receptor 1 | 0.18421 | Progesterone
 | 0.14052 | RARA: retinoic acid receptor, alpha |
704 | N | N | N | N | Imatinib mesylate
 | RARB: retinoic acid receptor, beta | 0.31372 | Tazarotene
 | 0.17163 | RORA: RAR-related orphan receptor A |
705 | N | N | N | N | Desogestrel
 | ESRRG: estrogen-related receptor gamma | 0.075000 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
706 | N | N | N | N | Paricalcitol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.33333 | Tretinoin
 | 0.037160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
707 | N | N | N | N | Flutamide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.13725 | Telmisartan
 | 0.063846 | AR: androgen receptor |
708 | N | N | N | N | Cholecalciferol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.33333 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
709 | N | N | N | N | Etretinate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.13725 | Mifepristone
 | 0.095503 | RARG: retinoic acid receptor, gamma |
710 | N | N | N | N | Loteprednol etabonate
 | RXRB: retinoid X receptor, beta | 0.18750 | Tazarotene
 | 0.10128 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
711 | N | N | N | N | Dihydrotachysterol
 | RXRB: retinoid X receptor, beta | 0.34210 | Tretinoin
 | 0.10984 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
712 | N | N | N | N | Budesonide
 | ESRRG: estrogen-related receptor gamma | 0.10870 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
713 | N | N | N | N | Imatinib mesylate
 | ESRRG: estrogen-related receptor gamma | 0.25265 | Diethylstilbestrol
 | 0.094696 | RORA: RAR-related orphan receptor A |
714 | N | N | N | N | Estramustine
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.25000 | Clofibrate
 | 0.096117 | ESR2: estrogen receptor 2 (ER beta) |
715 | N | N | N | N | Ergocalciferol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.34210 | Tretinoin
 | 0.037160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
716 | N | N | N | N | Paricalcitol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.067797 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
717 | N | N | N | N | Cholecalciferol
 | ESR2: estrogen receptor 2 (ER beta) | 0.29730 | Estradiol
 | 0.10255 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
718 | N | N | N | N | Paricalcitol
 | RORC: RAR-related orphan receptor C | 0.33333 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
719 | N | N | N | N | Clofibrate
 | ESRRB: estrogen-related receptor beta | 0.33333 | Diethylstilbestrol
 | 0.12375 | PPARA: peroxisome proliferator-activated receptor alpha |
720 | N | N | N | N | Butamben
 | RXRB: retinoid X receptor, beta | 0.34483 | Tazarotene
 | 0.11677 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
721 | N | N | N | N | Estramustine
 | RXRG: retinoid X receptor, gamma | 0.28571 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
722 | N | N | N | N | Progesterone
 | RARB: retinoic acid receptor, beta | 0.18421 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
723 | N | N | N | N | Loteprednol etabonate
 | ESR2: estrogen receptor 2 (ER beta) | 0.38636 | Estramustine
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
724 | N | N | N | N | Phenobarbital
 | ESR2: estrogen receptor 2 (ER beta) | 0.23333 | Diethylstilbestrol
 | 0.13704 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
725 | N | N | N | N | Loteprednol etabonate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.30435 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
726 | N | N | N | N | Fluoxymesterone
 | RARB: retinoic acid receptor, beta | 0.17949 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
727 | N | N | N | N | Medroxyprogesterone acetate
 | RARG: retinoic acid receptor, gamma | 0.19048 | Tretinoin
 | 0.087116 | PGR: progesterone receptor |
728 | N | N | N | N | Butamben
 | RARG: retinoic acid receptor, gamma | 0.34483 | Tazarotene
 | 0.16039 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
729 | N | N | N | N | Spironolactone
 | ESRRA: estrogen-related receptor alpha | 0.042553 | Diethylstilbestrol
 | 0.13692 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
730 | N | N | N | N | Budesonide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.090909 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
731 | N | N | N | N | Estramustine
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.29546 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
732 | N | N | N | N | Chenodiol
 | RARG: retinoic acid receptor, gamma | 0.21951 | Tretinoin
 | 0.19161 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
733 | N | N | N | N | Pregnenolone
 | RORB: RAR-related orphan receptor B | 0.18421 | Tretinoin
 | 0.14754 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
734 | N | N | N | N | Dihydrotachysterol
 | RORC: RAR-related orphan receptor C | 0.34210 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
735 | N | N | N | N | Fluoxymesterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.40541 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
736 | N | N | N | N | Ergocalciferol
 | RORB: RAR-related orphan receptor B | 0.34210 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
737 | N | N | N | N | Ethynodiol diacetate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.45714 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
738 | N | N | N | N | Fluoxymesterone
 | RORC: RAR-related orphan receptor C | 0.17949 | Tretinoin
 | 0.081057 | ESR1: estrogen receptor 1 |
739 | N | N | N | N | Fluoxymesterone
 | ESRRA: estrogen-related receptor alpha | 0.10000 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
740 | N | N | N | N | Rosiglitazone maleate
 | RXRG: retinoid X receptor, gamma | 0.26087 | Tazarotene
 | 0.029508 | PPARG: peroxisome proliferator-activated receptor gamma |
741 | N | N | N | N | Imatinib mesylate
 | RXRG: retinoid X receptor, gamma | 0.31372 | Tazarotene
 | 0.038021 | RORA: RAR-related orphan receptor A |
742 | N | N | N | N | Dydrogesterone
 | RARA: retinoic acid receptor, alpha | 0.18421 | Tretinoin
 | 0.084891 | PGR: progesterone receptor |
743 | N | N | N | N | Pregnenolone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.090909 | Fenofibrate
 | 0.14611 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
744 | N | N | N | N | Paricalcitol
 | RXRG: retinoid X receptor, gamma | 0.33333 | Tretinoin
 | 0.043160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
745 | N | N | N | N | Hydrocortisone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.092593 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
746 | N | N | N | N | Amcinonide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.038462 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
747 | N | N | N | N | Nilutamide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025641 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
748 | N | N | N | N | Raloxifene hydrochloride
 | RARB: retinoic acid receptor, beta | 0.30435 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
749 | N | N | N | N | Norethindrone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025641 | Palmitic acid
 | 0.097154 | PGR: progesterone receptor |
750 | N | N | N | N | Fulvestrant
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.23729 | Mifepristone
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
751 | N | N | N | N | Levonorgestrel
 | RXRB: retinoid X receptor, beta | 0.12500 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
752 | N | N | N | N | Norgestrel
 | RXRB: retinoid X receptor, beta | 0.12500 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
753 | N | N | N | N | Telmisartan
 | RARB: retinoic acid receptor, beta | 0.23077 | Tazarotene
 | 0.20203 | PPARG: peroxisome proliferator-activated receptor gamma |
754 | N | N | N | N | Dihydrotachysterol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.34210 | Tretinoin
 | 0.037160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
755 | N | N | N | N | Bicalutamide
 | RARA: retinoic acid receptor, alpha | 0.31707 | Tazarotene
 | 0.087217 | AR: androgen receptor |
756 | N | N | N | N | Loteprednol etabonate
 | RARB: retinoic acid receptor, beta | 0.18750 | Tazarotene
 | 0.096751 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
757 | N | N | N | N | Rifampin
 | RXRB: retinoid X receptor, beta | 0.19718 | Etretinate
 | 0.11677 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
758 | N | N | N | N | Ethinyl estradiol
 | RORA: RAR-related orphan receptor A | 0.28205 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
759 | N | N | N | N | Ergocalciferol
 | RXRB: retinoid X receptor, beta | 0.34210 | Tretinoin
 | 0.10984 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
760 | N | N | N | N | Estradiol
 | RARB: retinoic acid receptor, beta | 0.25000 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
761 | N | N | N | N | Butamben
 | RXRA: retinoid X receptor, alpha | 0.34483 | Tazarotene
 | 0.12632 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
762 | N | N | N | N | Fulvestrant
 | RXRA: retinoid X receptor, alpha | 0.17857 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
763 | N | N | N | N | Rosiglitazone maleate
 | RXRB: retinoid X receptor, beta | 0.26087 | Tazarotene
 | 0.14366 | PPARG: peroxisome proliferator-activated receptor gamma |
764 | N | N | N | N | Estramustine
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.26829 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
765 | N | N | N | N | Norethindrone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.11429 | Phenobarbital
 | 0.092601 | PGR: progesterone receptor |
766 | N | N | N | N | Amcinonide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.081633 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
767 | N | N | N | N | Chenodiol
 | RXRG: retinoid X receptor, gamma | 0.21951 | Tretinoin
 | 0.036481 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
768 | N | N | N | N | Pregnenolone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.050847 | Telmisartan
 | 0.16215 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
769 | N | N | N | N | Loteprednol etabonate
 | RARG: retinoic acid receptor, gamma | 0.18750 | Tazarotene
 | 0.099896 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
770 | N | N | N | N | Hydrocortisone
 | ESRRG: estrogen-related receptor gamma | 0.095238 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
771 | N | N | N | N | Budesonide
 | ESRRA: estrogen-related receptor alpha | 0.10870 | Diethylstilbestrol
 | 0.15441 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
772 | N | N | N | N | Raloxifene hydrochloride
 | RORB: RAR-related orphan receptor B | 0.30435 | Tazarotene
 | 0.095294 | ESR2: estrogen receptor 2 (ER beta) |
773 | N | N | N | N | Rosiglitazone maleate
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.10000 | Tretinoin
 | 0.028455 | PPARG: peroxisome proliferator-activated receptor gamma |
774 | N | N | N | N | Fluoxymesterone
 | ESRRG: estrogen-related receptor gamma | 0.10000 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
775 | N | N | N | N | Estrone sodium sulfate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.35714 | Mifepristone
 | 0.12027 | ESR1: estrogen receptor 1 |
776 | N | N | N | N | Fulvestrant
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.23729 | Mifepristone
 | 0.12278 | ESR2: estrogen receptor 2 (ER beta) |
777 | N | N | N | N | Paricalcitol
 | RXRA: retinoid X receptor, alpha | 0.33333 | Tretinoin
 | 0.13066 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
778 | N | N | N | N | Desogestrel
 | RXRA: retinoid X receptor, alpha | 0.12500 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
779 | N | N | N | N | Estramustine
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.11905 | Palmitic acid
 | 0.14814 | ESR2: estrogen receptor 2 (ER beta) |
780 | N | N | N | N | Loteprednol etabonate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.083333 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
781 | N | N | N | N | Estrone sodium sulfate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.20000 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
782 | N | N | N | N | Medroxyprogesterone acetate
 | RARB: retinoic acid receptor, beta | 0.19048 | Tretinoin
 | 0.078278 | PGR: progesterone receptor |
783 | N | N | N | N | Estradiol
 | RARG: retinoic acid receptor, gamma | 0.25000 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
784 | N | N | N | N | Raloxifene hydrochloride
 | RARG: retinoic acid receptor, gamma | 0.30435 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
785 | N | N | N | N | Dydrogesterone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.090909 | Fenofibrate
 | 0.059277 | PGR: progesterone receptor |
786 | N | N | N | N | Fulvestrant
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.23077 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
787 | N | N | N | N | Fluoxymesterone
 | RORB: RAR-related orphan receptor B | 0.17949 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
788 | N | N | N | N | Ergocalciferol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.32609 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
789 | N | N | N | N | Flutamide
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.068182 | Cholecalciferol
 | 0.067869 | AR: androgen receptor |
790 | N | N | N | N | Budesonide
 | ESRRB: estrogen-related receptor beta | 0.10870 | Diethylstilbestrol
 | 0.14423 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
791 | N | N | N | N | Norethindrone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.35135 | Chenodiol
 | 0.077571 | PGR: progesterone receptor |
792 | N | N | N | N | Pregnenolone
 | RARA: retinoic acid receptor, alpha | 0.18421 | Tretinoin
 | 0.16725 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
793 | N | N | N | N | Flutamide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.027778 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
794 | N | N | N | N | Dienestrol
 | RARA: retinoic acid receptor, alpha | 0.36364 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
795 | N | N | N | N | Progesterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.45714 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
796 | N | N | N | N | Cholesterol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.19048 | Tretinoin
 | 0.017933 | RORA: RAR-related orphan receptor A |
797 | N | N | N | N | Desogestrel
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.34210 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
798 | N | N | N | N | Progesterone
 | RORB: RAR-related orphan receptor B | 0.18421 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
799 | N | N | N | N | Telmisartan
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.10909 | Tretinoin
 | 0.028455 | PPARG: peroxisome proliferator-activated receptor gamma |
800 | N | N | N | N | Imatinib mesylate
 | RARG: retinoic acid receptor, gamma | 0.31372 | Tazarotene
 | 0.16278 | RORA: RAR-related orphan receptor A |
801 | N | N | N | N | Levonorgestrel
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.14286 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
802 | N | N | N | N | Norgestrel
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.14286 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
803 | N | N | N | N | Oxandrolone
 | RARA: retinoic acid receptor, alpha | 0.15790 | Tretinoin
 | 0.087217 | AR: androgen receptor |
804 | N | N | N | N | Estrone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.20455 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
805 | N | N | N | N | Desogestrel
 | ESRRB: estrogen-related receptor beta | 0.075000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
806 | N | N | N | N | Fluoxymesterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.17949 | Tretinoin
 | 0.026027 | ESR1: estrogen receptor 1 |
807 | N | N | N | N | Telmisartan
 | RARG: retinoic acid receptor, gamma | 0.23077 | Tazarotene
 | 0.19825 | PPARG: peroxisome proliferator-activated receptor gamma |
808 | N | N | N | N | Clomiphene citrate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.19149 | Butamben
 | 0.095273 | ESR1: estrogen receptor 1 |
809 | N | N | N | N | Calcitriol
 | RARA: retinoic acid receptor, alpha | 0.23810 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
810 | N | N | N | N | Estradiol
 | RORA: RAR-related orphan receptor A | 0.33333 | Cholesterol
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
811 | N | N | N | N | Ethinyl estradiol
 | RARA: retinoic acid receptor, alpha | 0.27027 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
812 | N | N | N | N | Flutamide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.16129 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
813 | N | N | N | N | Budesonide
 | RARA: retinoic acid receptor, alpha | 0.15217 | Tretinoin
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
814 | N | N | N | N | Desogestrel
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.43750 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
815 | N | N | N | N | Clofibrate
 | ESRRA: estrogen-related receptor alpha | 0.33333 | Diethylstilbestrol
 | 0.11006 | PPARA: peroxisome proliferator-activated receptor alpha |
816 | N | N | N | N | Hydrocortisone
 | ESRRA: estrogen-related receptor alpha | 0.095238 | Diethylstilbestrol
 | 0.15441 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
817 | N | N | N | N | Desogestrel
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.051282 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
818 | N | N | N | N | Ergocalciferol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.32609 | Mifepristone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
819 | N | N | N | N | Fulvestrant
 | RXRB: retinoid X receptor, beta | 0.17857 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
820 | N | N | N | N | Isotretinoin
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.093023 | Fenofibrate
 | 0.20153 | RARA: retinoic acid receptor, alpha |
821 | N | N | N | N | Spironolactone
 | ESRRG: estrogen-related receptor gamma | 0.042553 | Diethylstilbestrol
 | 0.13025 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
822 | N | N | N | N | Rifampin
 | RXRA: retinoid X receptor, alpha | 0.19718 | Etretinate
 | 0.12632 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
823 | N | N | N | N | Eplerenone
 | RORC: RAR-related orphan receptor C | 0.15556 | Tretinoin
 | 0.064847 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
824 | N | N | N | N | Budesonide
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15217 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
825 | N | N | N | N | Estradiol
 | RORB: RAR-related orphan receptor B | 0.25000 | Tazarotene
 | 0.095294 | ESR2: estrogen receptor 2 (ER beta) |
826 | N | N | N | N | Estrone
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
827 | N | N | N | N | Rosiglitazone maleate
 | PGR: progesterone receptor | 0.18182 | Mifepristone
 | 0.069755 | PPARG: peroxisome proliferator-activated receptor gamma |
828 | N | N | N | N | Tazarotene
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.10417 | Cholecalciferol
 | 0.18311 | RARG: retinoic acid receptor, gamma |
829 | N | N | N | N | Mometasone furoate
 | RXRG: retinoid X receptor, gamma | 0.22449 | Tazarotene
 | 0.035880 | PGR: progesterone receptor |
830 | N | N | N | N | Nandrolone phenpropionate
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tazarotene
 | 0.087217 | AR: androgen receptor |
831 | N | N | N | N | Ethynodiol diacetate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.36585 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
832 | N | N | N | N | Estramustine
 | RORB: RAR-related orphan receptor B | 0.28571 | Tazarotene
 | 0.095294 | ESR2: estrogen receptor 2 (ER beta) |
833 | N | N | N | N | Hydrocortisone
 | ESR2: estrogen receptor 2 (ER beta) | 0.35294 | Estradiol
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
834 | N | N | N | N | Bicalutamide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.044444 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
835 | N | N | N | N | Dydrogesterone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.11111 | Phenobarbital
 | 0.092601 | PGR: progesterone receptor |
836 | N | N | N | N | Nilutamide
 | RXRA: retinoid X receptor, alpha | 0.20513 | Tazarotene
 | 0.10468 | AR: androgen receptor |
837 | N | N | N | N | Paricalcitol
 | RXRB: retinoid X receptor, beta | 0.33333 | Tretinoin
 | 0.10984 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
838 | N | N | N | N | Estrone sodium sulfate
 | RARA: retinoic acid receptor, alpha | 0.21951 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
839 | N | N | N | N | Hydrocortisone
 | ESRRB: estrogen-related receptor beta | 0.095238 | Diethylstilbestrol
 | 0.14423 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
840 | N | N | N | N | Oxandrolone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025641 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
841 | N | N | N | N | Loteprednol etabonate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.088889 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
842 | N | N | N | N | Progesterone
 | RXRG: retinoid X receptor, gamma | 0.18421 | Tretinoin
 | 0.038684 | ESR1: estrogen receptor 1 |
843 | N | N | N | N | Eplerenone
 | RARG: retinoic acid receptor, gamma | 0.17021 | Tazarotene
 | 0.095503 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
844 | N | N | N | N | Levonorgestrel
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.051282 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
845 | N | N | N | N | Norgestrel
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.051282 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
846 | N | N | N | N | Nandrolone phenpropionate
 | RXRG: retinoid X receptor, gamma | 0.25000 | Tazarotene
 | 0.028328 | AR: androgen receptor |
847 | N | N | N | N | Oxandrolone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15790 | Tretinoin
 | 0.019212 | AR: androgen receptor |
848 | N | N | N | N | Amcinonide
 | RXRG: retinoid X receptor, gamma | 0.15094 | Tazarotene
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
849 | N | N | N | N | Desogestrel
 | RXRB: retinoid X receptor, beta | 0.12500 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
850 | N | N | N | N | Nilutamide
 | RXRG: retinoid X receptor, gamma | 0.20513 | Tazarotene
 | 0.028328 | AR: androgen receptor |
851 | N | N | N | N | Amcinonide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.078125 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
852 | N | N | N | N | Hydrocortisone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.085106 | Fenofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
853 | N | N | N | N | Progesterone
 | RORC: RAR-related orphan receptor C | 0.18421 | Tretinoin
 | 0.081057 | ESR1: estrogen receptor 1 |
854 | N | N | N | N | Mometasone furoate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15556 | Phenobarbital
 | 0.092601 | PGR: progesterone receptor |
855 | N | N | N | N | Eplerenone
 | RORB: RAR-related orphan receptor B | 0.17021 | Tazarotene
 | 0.071358 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
856 | N | N | N | N | Nandrolone phenpropionate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.066667 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
857 | N | N | N | N | Spironolactone
 | ESRRB: estrogen-related receptor beta | 0.042553 | Diethylstilbestrol
 | 0.11497 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
858 | N | N | N | N | Progesterone
 | ESRRA: estrogen-related receptor alpha | 0.048780 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
859 | N | N | N | N | Butamben
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17949 | Mifepristone
 | 0.071609 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
860 | N | N | N | N | Mometasone furoate
 | RORA: RAR-related orphan receptor A | 0.26000 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
861 | N | N | N | N | Nilutamide
 | RXRB: retinoid X receptor, beta | 0.20513 | Tazarotene
 | 0.093636 | AR: androgen receptor |
862 | N | N | N | N | Progesterone
 | ESRRG: estrogen-related receptor gamma | 0.048780 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
863 | N | N | N | N | Fluoxymesterone
 | ESRRB: estrogen-related receptor beta | 0.10000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
864 | N | N | N | N | Telmisartan
 | RXRA: retinoid X receptor, alpha | 0.23077 | Tazarotene
 | 0.17057 | PPARG: peroxisome proliferator-activated receptor gamma |
865 | N | N | N | N | Phenobarbital
 | RORB: RAR-related orphan receptor B | 0.16667 | Tazarotene
 | 0.11617 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
866 | N | N | N | N | Ethinyl estradiol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.31579 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
867 | N | N | N | N | Budesonide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.098039 | Fenofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
868 | N | N | N | N | Spironolactone
 | RARA: retinoic acid receptor, alpha | 0.15909 | Tretinoin
 | 0.087093 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
869 | N | N | N | N | Bicalutamide
 | RXRA: retinoid X receptor, alpha | 0.31707 | Tazarotene
 | 0.10468 | AR: androgen receptor |
870 | N | N | N | N | Isotretinoin
 | RORA: RAR-related orphan receptor A | 0.19048 | Cholesterol
 | 0.15182 | RARA: retinoic acid receptor, alpha |
871 | N | N | N | N | Ethynodiol diacetate
 | RORA: RAR-related orphan receptor A | 0.40000 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
872 | N | N | N | N | Paricalcitol
 | RORB: RAR-related orphan receptor B | 0.33333 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
873 | N | N | N | N | Paricalcitol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.29167 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
874 | N | N | N | N | Cholesterol
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Estradiol
 | 0.088647 | RORA: RAR-related orphan receptor A |
875 | N | N | N | N | Rifampin
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.12500 | Tretinoin
 | 0.035170 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
876 | N | N | N | N | Estradiol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15625 | Phenobarbital
 | 0.13704 | ESR2: estrogen receptor 2 (ER beta) |
877 | N | N | N | N | Flutamide
 | RXRA: retinoid X receptor, alpha | 0.22222 | Tazarotene
 | 0.10468 | AR: androgen receptor |
878 | N | N | N | N | Nilutamide
 | RARG: retinoic acid receptor, gamma | 0.20513 | Tazarotene
 | 0.091042 | AR: androgen receptor |
879 | N | N | N | N | Chenodiol
 | RXRA: retinoid X receptor, alpha | 0.21951 | Tretinoin
 | 0.15800 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
880 | N | N | N | N | Bicalutamide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17308 | Mifepristone
 | 0.20529 | AR: androgen receptor |
881 | N | N | N | N | Mometasone furoate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.23529 | Cholecalciferol
 | 0.060029 | PGR: progesterone receptor |
882 | N | N | N | N | Dihydrotachysterol
 | RORB: RAR-related orphan receptor B | 0.34210 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
883 | N | N | N | N | Ethynodiol diacetate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.12821 | Clofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
884 | N | N | N | N | Raloxifene hydrochloride
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.13043 | Phenobarbital
 | 0.13704 | ESR2: estrogen receptor 2 (ER beta) |
885 | N | N | N | N | Eplerenone
 | RXRB: retinoid X receptor, beta | 0.17021 | Tazarotene
 | 0.082031 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
886 | N | N | N | N | Nandrolone phenpropionate
 | RXRA: retinoid X receptor, alpha | 0.25000 | Tazarotene
 | 0.10468 | AR: androgen receptor |
887 | N | N | N | N | Dydrogesterone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025000 | Palmitic acid
 | 0.097154 | PGR: progesterone receptor |
888 | N | N | N | N | Dienestrol
 | RORA: RAR-related orphan receptor A | 0.25265 | Imatinib mesylate
 | 0.085339 | ESR1: estrogen receptor 1 |
889 | N | N | N | N | Desogestrel
 | RARA: retinoic acid receptor, alpha | 0.12500 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
890 | N | N | N | N | Clomiphene citrate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15686 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
891 | N | N | N | N | Testosterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.16216 | Tretinoin
 | 0.019212 | AR: androgen receptor |
892 | N | N | N | N | Chenodiol
 | RXRB: retinoid X receptor, beta | 0.21951 | Tretinoin
 | 0.13659 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
893 | N | N | N | N | Bicalutamide
 | RXRG: retinoid X receptor, gamma | 0.31707 | Tazarotene
 | 0.028328 | AR: androgen receptor |
894 | N | N | N | N | Estrone sodium sulfate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.35714 | Mifepristone
 | 0.13105 | ESR1: estrogen receptor 1 |
895 | N | N | N | N | Bicalutamide
 | RXRB: retinoid X receptor, beta | 0.31707 | Tazarotene
 | 0.093636 | AR: androgen receptor |
896 | N | N | N | N | Eplerenone
 | ESRRA: estrogen-related receptor alpha | 0.041667 | Diethylstilbestrol
 | 0.13692 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
897 | N | N | N | N | Nandrolone phenpropionate
 | RXRB: retinoid X receptor, beta | 0.25000 | Tazarotene
 | 0.093636 | AR: androgen receptor |
898 | N | N | N | N | Dienestrol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.086957 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
899 | N | N | N | N | Fluoxymesterone
 | RXRG: retinoid X receptor, gamma | 0.17949 | Tretinoin
 | 0.038684 | ESR1: estrogen receptor 1 |
900 | N | N | N | N | Flutamide
 | RXRB: retinoid X receptor, beta | 0.22222 | Tazarotene
 | 0.093636 | AR: androgen receptor |
901 | N | N | N | N | Fulvestrant
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.094340 | Phenobarbital
 | 0.13704 | ESR2: estrogen receptor 2 (ER beta) |
902 | N | N | N | N | Flutamide
 | RXRG: retinoid X receptor, gamma | 0.22222 | Tazarotene
 | 0.028328 | AR: androgen receptor |
903 | N | N | N | N | Eplerenone
 | RARB: retinoic acid receptor, beta | 0.17021 | Tazarotene
 | 0.084972 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
904 | N | N | N | N | Mometasone furoate
 | RXRB: retinoid X receptor, beta | 0.22449 | Tazarotene
 | 0.096643 | PGR: progesterone receptor |
905 | N | N | N | N | Levonorgestrel
 | RARA: retinoic acid receptor, alpha | 0.12500 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
906 | N | N | N | N | Norgestrel
 | RARA: retinoic acid receptor, alpha | 0.12500 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
907 | N | N | N | N | Clomiphene citrate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.090909 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
908 | N | N | N | N | Estrone
 | RXRA: retinoid X receptor, alpha | 0.25000 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
909 | N | N | N | N | Desogestrel
 | RORA: RAR-related orphan receptor A | 0.37838 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
910 | N | N | N | N | Cholecalciferol
 | RORC: RAR-related orphan receptor C | 0.25000 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
911 | N | N | N | N | Mometasone furoate
 | RXRA: retinoid X receptor, alpha | 0.22449 | Tazarotene
 | 0.10416 | PGR: progesterone receptor |
912 | N | N | N | N | Phenobarbital
 | RARG: retinoic acid receptor, gamma | 0.16667 | Tazarotene
 | 0.18237 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
913 | N | N | N | N | Cholesterol
 | ESRRB: estrogen-related receptor beta | 0.066667 | Diethylstilbestrol
 | 0.091736 | RORA: RAR-related orphan receptor A |
914 | N | N | N | N | Ethinyl estradiol
 | RXRA: retinoid X receptor, alpha | 0.27027 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
915 | N | N | N | N | Dienestrol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.19355 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
916 | N | N | N | N | Levonorgestrel
 | RARG: retinoic acid receptor, gamma | 0.12500 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
917 | N | N | N | N | Norgestrel
 | RARG: retinoic acid receptor, gamma | 0.12500 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
918 | N | N | N | N | Budesonide
 | RORC: RAR-related orphan receptor C | 0.15217 | Tretinoin
 | 0.063234 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
919 | N | N | N | N | Nilutamide
 | RARB: retinoic acid receptor, beta | 0.20513 | Tazarotene
 | 0.084560 | AR: androgen receptor |
920 | N | N | N | N | Butamben
 | RORB: RAR-related orphan receptor B | 0.34483 | Tazarotene
 | 0.14754 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
921 | N | N | N | N | Medroxyprogesterone acetate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.36585 | Chenodiol
 | 0.077571 | PGR: progesterone receptor |
922 | N | N | N | N | Progesterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.18421 | Tretinoin
 | 0.026027 | ESR1: estrogen receptor 1 |
923 | N | N | N | N | Eplerenone
 | RXRA: retinoid X receptor, alpha | 0.17021 | Tazarotene
 | 0.090569 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
924 | N | N | N | N | Cholesterol
 | ESRRA: estrogen-related receptor alpha | 0.066667 | Diethylstilbestrol
 | 0.094996 | RORA: RAR-related orphan receptor A |
925 | N | N | N | N | Nilutamide
 | ESR2: estrogen receptor 2 (ER beta) | 0.24390 | Estramustine
 | 0.11996 | AR: androgen receptor |
926 | N | N | N | N | Telmisartan
 | RXRG: retinoid X receptor, gamma | 0.23077 | Tazarotene
 | 0.029508 | PPARG: peroxisome proliferator-activated receptor gamma |
927 | N | N | N | N | Fulvestrant
 | RARA: retinoic acid receptor, alpha | 0.17857 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
928 | N | N | N | N | Calcitriol
 | ESRRB: estrogen-related receptor beta | 0.086957 | Diethylstilbestrol
 | 0.14119 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
929 | N | N | N | N | Hydrocortisone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.14286 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
930 | N | N | N | N | Progesterone
 | ESRRB: estrogen-related receptor beta | 0.048780 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
931 | N | N | N | N | Bicalutamide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15000 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
932 | N | N | N | N | Telmisartan
 | RXRB: retinoid X receptor, beta | 0.23077 | Tazarotene
 | 0.14366 | PPARG: peroxisome proliferator-activated receptor gamma |
933 | N | N | N | N | Norgestrel
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.30769 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
934 | N | N | N | N | Levonorgestrel
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.30769 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
935 | N | N | N | N | Estrone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.20000 | Clofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
936 | N | N | N | N | Paricalcitol
 | ESRRB: estrogen-related receptor beta | 0.086957 | Diethylstilbestrol
 | 0.14119 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
937 | N | N | N | N | Phenobarbital
 | RXRG: retinoid X receptor, gamma | 0.16667 | Tazarotene
 | 0.032958 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
938 | N | N | N | N | Dydrogesterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.18421 | Tretinoin
 | 0.020772 | PGR: progesterone receptor |
939 | N | N | N | N | Estrone
 | RXRB: retinoid X receptor, beta | 0.25000 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
940 | N | N | N | N | Testosterone
 | RARA: retinoic acid receptor, alpha | 0.16216 | Tretinoin
 | 0.087217 | AR: androgen receptor |
941 | N | N | N | N | Telmisartan
 | PGR: progesterone receptor | 0.14516 | Mifepristone
 | 0.069755 | PPARG: peroxisome proliferator-activated receptor gamma |
942 | N | N | N | N | Palmitic acid
 | RORB: RAR-related orphan receptor B | 0.11111 | Tretinoin
 | 0.10743 | HNF4G: hepatocyte nuclear factor 4, gamma |
943 | N | N | N | N | Ethinyl estradiol
 | RXRB: retinoid X receptor, beta | 0.27027 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
944 | N | N | N | N | Estradiol
 | RXRG: retinoid X receptor, gamma | 0.25000 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
945 | N | N | N | N | Testosterone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.026316 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
946 | N | N | N | N | Phenobarbital
 | RARB: retinoic acid receptor, beta | 0.16667 | Tazarotene
 | 0.17553 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
947 | N | N | N | N | Oxandrolone
 | RORC: RAR-related orphan receptor C | 0.15790 | Tretinoin
 | 0.057274 | AR: androgen receptor |
948 | N | N | N | N | Flutamide
 | RARG: retinoic acid receptor, gamma | 0.22222 | Tazarotene
 | 0.091042 | AR: androgen receptor |
949 | N | N | N | N | Paricalcitol
 | ESR2: estrogen receptor 2 (ER beta) | 0.28205 | Estradiol
 | 0.10255 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
950 | N | N | N | N | Butamben
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17949 | Mifepristone
 | 0.075614 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
951 | N | N | N | N | Levonorgestrel
 | RORB: RAR-related orphan receptor B | 0.12500 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
952 | N | N | N | N | Norgestrel
 | RORB: RAR-related orphan receptor B | 0.12500 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
953 | N | N | N | N | Bicalutamide
 | RORB: RAR-related orphan receptor B | 0.31707 | Tazarotene
 | 0.060766 | AR: androgen receptor |
954 | N | N | N | N | Isotretinoin
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.11111 | Palmitic acid
 | 0.17474 | RARA: retinoic acid receptor, alpha |
955 | N | N | N | N | Amcinonide
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.13725 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
956 | N | N | N | N | Amcinonide
 | RXRA: retinoid X receptor, alpha | 0.15094 | Tazarotene
 | 0.11451 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
957 | N | N | N | N | Spironolactone
 | RXRG: retinoid X receptor, gamma | 0.15909 | Tretinoin
 | 0.035964 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
958 | N | N | N | N | Bicalutamide
 | RARG: retinoic acid receptor, gamma | 0.31707 | Tazarotene
 | 0.091042 | AR: androgen receptor |
959 | N | N | N | N | Pregnenolone
 | ESR2: estrogen receptor 2 (ER beta) | 0.38710 | Estradiol
 | 0.088787 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
960 | N | N | N | N | Levonorgestrel
 | RARB: retinoic acid receptor, beta | 0.12500 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
961 | N | N | N | N | Norgestrel
 | RARB: retinoic acid receptor, beta | 0.12500 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
962 | N | N | N | N | Estramustine
 | RORA: RAR-related orphan receptor A | 0.28106 | Cholesterol
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
963 | N | N | N | N | Loteprednol etabonate
 | RORB: RAR-related orphan receptor B | 0.18750 | Tazarotene
 | 0.065341 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
964 | N | N | N | N | Imatinib mesylate
 | RXRB: retinoid X receptor, beta | 0.31372 | Tazarotene
 | 0.10316 | RORA: RAR-related orphan receptor A |
965 | N | N | N | N | Isotretinoin
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17391 | Mifepristone
 | 0.087093 | RARA: retinoic acid receptor, alpha |
966 | N | N | N | N | Loteprednol etabonate
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.14894 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
967 | N | N | N | N | Raloxifene hydrochloride
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.14035 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
968 | N | N | N | N | Nandrolone phenpropionate
 | RARG: retinoic acid receptor, gamma | 0.25000 | Tazarotene
 | 0.091042 | AR: androgen receptor |
969 | N | N | N | N | Amcinonide
 | RXRB: retinoid X receptor, beta | 0.15094 | Tazarotene
 | 0.10128 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
970 | N | N | N | N | Cholesterol
 | ESRRG: estrogen-related receptor gamma | 0.066667 | Diethylstilbestrol
 | 0.094696 | RORA: RAR-related orphan receptor A |
971 | N | N | N | N | Nandrolone phenpropionate
 | RORB: RAR-related orphan receptor B | 0.25000 | Tazarotene
 | 0.060766 | AR: androgen receptor |
972 | N | N | N | N | Medroxyprogesterone acetate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.070175 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
973 | N | N | N | N | Progesterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.37838 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
974 | N | N | N | N | Testosterone
 | RORC: RAR-related orphan receptor C | 0.16216 | Tretinoin
 | 0.057274 | AR: androgen receptor |
975 | N | N | N | N | Cholecalciferol
 | RORB: RAR-related orphan receptor B | 0.25000 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
976 | N | N | N | N | Nilutamide
 | ESRRA: estrogen-related receptor alpha | 0.20000 | Diethylstilbestrol
 | 0.12419 | AR: androgen receptor |
977 | N | N | N | N | Ethynodiol diacetate
 | RORC: RAR-related orphan receptor C | 0.16279 | Tretinoin
 | 0.081057 | ESR1: estrogen receptor 1 |
978 | N | N | N | N | Fenofibrate
 | RORC: RAR-related orphan receptor C | 0.093023 | Tretinoin
 | 0.14184 | PPARA: peroxisome proliferator-activated receptor alpha |
979 | N | N | N | N | Rifampin
 | RORB: RAR-related orphan receptor B | 0.16667 | Tazarotene
 | 0.14754 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
980 | N | N | N | N | Estrone sodium sulfate
 | RXRA: retinoid X receptor, alpha | 0.21951 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
981 | N | N | N | N | Palmitic acid
 | RARB: retinoic acid receptor, beta | 0.11111 | Tretinoin
 | 0.18903 | HNF4G: hepatocyte nuclear factor 4, gamma |
982 | N | N | N | N | Estrone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.29730 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
983 | N | N | N | N | Desogestrel
 | RORB: RAR-related orphan receptor B | 0.12500 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
984 | N | N | N | N | Mometasone furoate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.039216 | Palmitic acid
 | 0.097154 | PGR: progesterone receptor |
985 | N | N | N | N | Clomiphene citrate
 | ESRRA: estrogen-related receptor alpha | 0.34783 | Diethylstilbestrol
 | 0.25410 | ESR1: estrogen receptor 1 |
986 | N | N | N | N | Imatinib mesylate
 | RXRA: retinoid X receptor, alpha | 0.31372 | Tazarotene
 | 0.11627 | RORA: RAR-related orphan receptor A |
987 | N | N | N | N | Eplerenone
 | ESRRG: estrogen-related receptor gamma | 0.041667 | Diethylstilbestrol
 | 0.13025 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
988 | N | N | N | N | Flutamide
 | RARB: retinoic acid receptor, beta | 0.22222 | Tazarotene
 | 0.084560 | AR: androgen receptor |
989 | N | N | N | N | Clomiphene citrate
 | ESRRG: estrogen-related receptor gamma | 0.34783 | Diethylstilbestrol
 | 0.25889 | ESR1: estrogen receptor 1 |
990 | N | N | N | N | Loteprednol etabonate
 | ESRRG: estrogen-related receptor gamma | 0.083333 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
991 | N | N | N | N | Mometasone furoate
 | RARG: retinoic acid receptor, gamma | 0.22449 | Tazarotene
 | 0.087116 | PGR: progesterone receptor |
992 | N | N | N | N | Medroxyprogesterone acetate
 | RORB: RAR-related orphan receptor B | 0.19048 | Tretinoin
 | 0.062441 | PGR: progesterone receptor |
993 | N | N | N | N | Budesonide
 | RXRG: retinoid X receptor, gamma | 0.15217 | Tretinoin
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
994 | N | N | N | N | Raloxifene hydrochloride
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.14546 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
995 | N | N | N | N | Calcitriol
 | ESRRG: estrogen-related receptor gamma | 0.086957 | Diethylstilbestrol
 | 0.14277 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
996 | N | N | N | N | Paricalcitol
 | ESRRG: estrogen-related receptor gamma | 0.086957 | Diethylstilbestrol
 | 0.14277 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
997 | N | N | N | N | Raloxifene hydrochloride
 | RXRG: retinoid X receptor, gamma | 0.30435 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
998 | N | N | N | N | Desogestrel
 | RARG: retinoic acid receptor, gamma | 0.12500 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
999 | N | N | N | N | Fluoxymesterone
 | RORA: RAR-related orphan receptor A | 0.44444 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
1000 | N | N | N | N | Cholesterol
 | RARB: retinoic acid receptor, beta | 0.19048 | Tretinoin
 | 0.17163 | RORA: RAR-related orphan receptor A |